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ABSTRACT 
Objectives of this study were to determine secular trends of diabetes prevalence in 
China and develop simple risk assessment algorithms for screening individuals with 
high-risk for diabetes or with undiagnosed diabetes in Chinese and Indian adults.  
Two consecutive population based surveys in Chinese and a prospective study in 
Mauritian Indians were involved in this study. The Chinese surveys were conducted 
in randomly selected populations aged 20-74 years in 2001-2002 (n=14 592) and 35-
74 years in 2006 (n=4416). A two-step screening strategy using fasting capillary 
plasma glucose (FCG) as first-line screening test followed by standard 2-hour 75g 
oral glucose tolerance tests (OGTTs) was applied to 12 436 individuals in 2001, while 
OGTTs were administrated to all participants together with FCG in 2006 and to 2156 
subjects in 2002. In Mauritius, two consecutive population based surveys were 
conducted in Mauritian Indians aged 20-65 years in 1987 and 1992; 3094 Indians 
(1141 men), who were not diagnosed as diabetes at baseline, were reexamined with 
OGTTs in 1992 and/or 1998. Diabetes and pre-diabetes was defined following 2006 
World Health Organization/ International Diabetes Federation Criteria.  
 
Age-standardized, as well as age- and sex-specific, prevalence of diabetes and pre-
diabetes in adult Chinese was significantly increased from 12.2% and 15.4% in 2001 
to 16.0% and 21.2% in 2006, respectively. A simple Chinese diabetes risk score was 
developed based on the data of Chinese survey 2001-2002 and validated in the 
population of survey 2006. The risk scores based on ? coefficients derived from the 
final Logistic regression model ranged from 3 – 32. When the score was applied to 
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the population of survey 2006, the area under operating characteristic curve (AUC) of 
the score for screening undiagnosed diabetes was 0.67 (95% CI, 0.65-0.70), which 
was lower than the AUC of FCG (0.76 [0.74-0.79]), but similar to that of HbA1c (0.68 
[0.65-0.71]).  At a cut-off point of 14, the sensitivity and specificity of the risk score 
in screening undiagnosed diabetes was 0.84 (0.81-0.88) and 0.40 (0.38-0.41).  
 
In Mauritian Indian, body mass index (BMI), waist girth, family history of diabetes 
(FH), and glucose was confirmed to be independent risk predictors for developing 
diabetes. Predicted probabilities for developing diabetes derived from a simple Cox 
regression model fitted with sex, FH, BMI and waist girth ranged from 0.05 to 0.64 in 
men and 0.03 to 0.49 in women. To predict the onset of diabetes, the AUC of the 
predicted probabilities was 0.62 (95% CI, 0.56-0.68) in men and 0.64(0.59-0.69) in 
women. At a cut-off point of 0.12, the sensitivity and specificity was 0.72(0.71-0.74) 
and 0.47(0.45-0.49) in men; and 0.77(0.75-0.78) and 0.50(0.48-0.52) in women, 
respectively.  
 
In conclusion, there was a rapid increase in prevalence of diabetes in Chinese adults 
from 2001 to 2006. The simple risk assessment algorithms based on age, obesity and 
family history of diabetes showed a moderate discrimination of diabetes from non-
diabetes, which may be used as first line screening tool for diabetes and pre-diabetes, 
and for health promotion purpose in Chinese and Indians. 
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TIIVISTELMÄ 
Tämän tutkimuksen tarkoituksena oli tutkia miten diabeteksen esiintyvyys on muuttunut 
Kiinassa ja kehittää kiinalaista ja intialaista alkuperää olevaa aikuisväestöä varten 
yksinkertaiset riskinarviointialgoritmit, joiden avulla voidaan tunnistaa henkilöt, joilla on 
suuri riski sairastua diabetekseen tai aiemmin diagnosoimaton diabetes. 
Tutkimus koostui kahdesta peräkkäisestä väestötutkimuksesta Kiinassa sekä 
Mauritiuksen intialaisväestön prospektiivisesta tutkimuksesta. Kiinalaisissa 
väestötutkimuksissa tehtiin satunnaisotanta 20-70 vuotiaista kiinalaisista vuosina 2001-
2002 (n=14592) ja 35-74 vuotiaista vuonna 2006 (n=4416). Seulonta suoritettiin 
kaksivaiheisena 12436 henkilölle vuonna 2001. Ensisijainen seulontatesti oli 
kapillaariverinäytteestä tehty paastoglukoosin määritys, jota seurasi normaali kahden 
tunnin 75g glukoosirasituskoe,. Glukoosirasituskoe ja kapillaarinäytteestä tehty 
paastoglukoosin määritys tehtiin kaikille tutkittaville vuonna 2006 ja 2156 tutkittavalle 
vuonna 2002.Mauritiuksen 20-65-vuotiaassa intialaisperäisessä väestössä toteutettiin 
kaksi peräkkäistä väestötutkimusta vuosina 1987 ja 1992. Niille 3094 intialaiselle (1141 
miestä), joilla ei todettu olevan diabetesta lähtötilanteessa, tehtiin glukoosirasituskokeet 
vuosina 1992 ja/tai 1998. Diabetes ja sen esiasteet määriteltiin vuoden 2006 World 
Health Organization/ International Diabetes Federation kriteerien mukaisesti.  
Ikävakioitu, ikä- ja sukupuolispesifinen diabeteksen ja sen esiasteiden vallitsevuus 
kiinalaisessa aikuisväestössä kasvoi merkitsevästi vuosien 2001 ja 2006 välillä; 
diabeteksen osalta 12.2 %:sta 16.0 %:iin ja esiasteiden osalta 15.4 % :sta 21.2 %:iin.  
Yksinkertainen kiinalainen diabeteksen riskitesti kehitettiin pohjautuen kiinalaiseen 
2001–2002 väestötutkimukseen ja sen osuvuus varmennettiin vuoden 2006 
väestötutkimusaineistolla. 
 
Logistisen regressiomallin kertoimiin (?) perustuvat riskipisteet vaihtelivat välillä 3-32. 
Kun riskipisteitä testattiin vuoden 2006 tutkimuksen väestöön, riskipisteiden AUC (ROC-
käyrän alle jäävä pinta-ala) pistemäärä diagnosoimattomalle diabetekselle oli 0.67 (95% 
CI, 0.65-0.70), tulos, joka oli alempi kuin kapillaarinäytteestä tehdyn paastoglukoosin 
määrityksen AUC ( 0.76 [0.74-0.79]), mutta samankaltainen kuin HbA1c:n AUC (0.68 
9 
 
[0.65-0.71]). Kun katkaisukohtana oli 14 riskitestipistettä, sen herkkyys aiemmin 
diagnosoimattoman diabeteksen toteamiselle oli 0.84 (0.81-0.88) ja herkkyys 0.40 (0.38-
0.41). 
 
Mauritiuksen intialaisväestön tutkimuksessa painoindeksi (BMI), vyötärön ympärys, 
suvussa esiintynyt diabetes ja glukoosi ennustivat itsenäisesti tulevaa diabetesta..Coxin 
regressiomallista johdetut diabeteksen kehittymisen todennäköisyysennusteet, kun 
mallissa selittäjinä olivat sukupuoli, suvussa esiintynyt diabetes, BMI ja vyötärön 
ympärys, vaihtelivat välillä ,0.05-0.64 miehillä ja 0.03-0.49 naisilla. Ennustettaessa 
diabeteksen alkamisajankohtaa, ennustetun todennäköisyyden AUC oli 0.62 (95% CI, 
0.56-0.68) miehillä ja 0.64(0.59-0.69) naisilla. Käytettäessä katkaisupisteenä 0.12:a, 
herkkyys oli 0.72(0.71-0.74) ja tarkkuus 0.47(0.45-0.49) miehillä. Vastaavat luvut 
naisilla olivat  0.77(0.75-0.78) ja 0.50(0.48-0.52). 
 
Yhteenvetona voidaan todeta, että diabeteksen esiintyvyys kasvoi nopeasi Kiinassa 
vuodesta 2001 vuoteen 2006. Yksinkertainen riskinarviointialgoritmi oli mahdollista 
kehittää. Se perustui ikään, lihavuuteen ja suvussa esiintyneeseen diabetekseen, osoitti 
kohtalaista erottelukykyä diabeteksen ja normaalin glukoosiaineenvaihdunnan välillä. 
Sitä voidaan käyttää terveyden edistämistarkoituksiin sekä ensisijaisena työkaluna 
seulottaessa diabetesta ja sen esiasteita kiinalaista ja intialaista alkuperää olevilla 
henkilöillä.
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ABBREVIATIONS 
ADA American Diabetes Association 
AUC Area under receiver operating characteristic curve 
BMI body mass index 
BP  blood pressure 
CI   confidence interval 
FH  family history of diabetes 
FPG fasting plasma glucose  
FCG  fasting capillary plasma glucose  
HbA1c  glycated hemoglobin A1c  
IDF International Diabetes Federation 
2hPG  post-challenge 2 hour plasma glucose  
Qd-DPP Qingdao Diabetes Prevention Program 
ROC  receiver operating characteristic curve 
SE   standard error 
SD  standard difference 
WHO World Health Organization 
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1. INTRODUCTION 
During the past few decades, the number of patients  with diabetes mellitus has been seen 
a dramatic increase in the world, which was about 175 million in 2000 and will continue 
to rise up to 366 million in 2030 (Wild et al. 2004). As the International Diabetes 
Federation (IDF) and World Health Organization (WHO) estimated, the epidemic of 
diabetes casts a heavy burden to the human society (http://www.idf.org/human-social-
and-economic-impact-diabetes, accessed18 June 2009). The devastating effects on the 
human health and social-economic development are alarming both in developed and 
developing countries, particularly in China and India, which hold the largest number of 
diabetic patients in the world (Wild et al. 2004).  According to the WHO estimate, China 
will lose the national income about $ 555.7 billion from the year of 2005 to 2015, and 
Indian $ 333.6 billion, which is definitely a heavy burden for their developing society and 
economy.  
 Under the pressure of the increasing burden of the disease, diabetes research has become 
important during the past decades. With the evidence accumulated, it is clear that both 
diabetes and its complications can be delayed or prevented with appropriate lifestyle 
intervention and/or drug treatment (Reichard et al. 1993; The Diabetes Control and 
Complications Trial Research Group 1995; Pan et al. 1997; United Kingdom Prospective 
Diabetes Study (UKPDS) Group 1998; United Kingdom Prospective Diabetes Study 
(UKPDS) Group 1998; Tuomilehto et al. 2001; Chiasson et al. 2002; Knowler et al. 2002; 
Ramachandran et al. 2006; Gerstein et al. 2008; Patel et al. 2008; Duckworth et al. 2009; 
Nathan et al. 2009; Turnbull et al. 2009). Early detection applying a simple, sensitive and 
acceptable screening tool is, therefore, crucial to enable early identification and 
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interventions (Tabák et al. 2009). Blood glucose test, both a diagnostic test and a 
screening tool, has been widely used in the past to screen for type 2 diabetes, which has a 
moderate to high sensitivity and specificity in spite of which type of blood glucose tests 
were applied (Bortheiry et al. 1994; Husseini et al. 2000; Daniel et al. 2002; Bennett et al. 
2007). Because blood glucose test is invasive, relatively expensive, time consuming, and 
requires fasting status and/or glucose ingestion, attempts have been made to assess the 
diabetes risk according to diabetes risk factors such as age, obesity, physical inactivity, 
diet, family history of diabetes, blood pressure, blood lipids, history of intermediate 
hyperglycaemia, gestational diabetes, and hypertension, etc. Different risk assessment 
algorithms have been developed recently and approved to be used in different screening 
programs. Most of those risk assessment tools was reported to have a moderate 
discrimination (Schwarz et al. 2009). However, a few risk assessment tools have been 
developed and evaluated in Chinese and Indian populations.  
 
Based on two population-based surveys in Qingdao, China, we have estimated the 
prevalence of type 2 diabetes and its secular increasing trend in Chinese adults. A simple 
risk score for screening diabetes was developed and its ability to discriminate diabetes 
from non-diabetes defined by 2-hour 75 gram oral glucose tolerance test (OGTTs) was 
evaluated and compared with that of fasting capillary plasma glucose (FCG) and glycated 
hemoglobin A1c (HbA1c) tests.  A simple risk score was also derived for Mauritian 
Indians based on prospective studies of two random population-based surveys.   
14 
 
2. REVIEW OF THE LITERATURE 
 
2.1 Definition, classification and diagnostic criteria for type 2 
diabetes mellitus 
2.1.1 Definition and classification of diabetes mellitus 
As in the 1999 WHO technical report for Definition, Diagnosis and Classification of 
Diabetes Mellitus and its Complications, diabetes mellitus was defined as “a metabolic 
disorder of multiple aetiology characterized by chronic hyperglycaemia with disturbances 
of carbohydrate, fat and protein metabolism resulting from defects in insulin secretion, 
insulin action, or both” (W.H.O Consultation 1999).  If it is not well treated, diabetes 
might result in a long-term damage, dysfunction, and failure of various organs, especially 
the eyes, kidneys, nerves, heart, etc. The typical symptoms for diabetes are increased 
thirst, increased hunger, frequent urination, unexplained weight loss, fatigue, etc. But, 
these symptoms are usually not present in all patients with type 2 diabetes, which makes 
the diseases undiagnosed for a long time (Harris et al. 1992; Thompson et al. 1996).  
 
Based on the clinical stages and aetiological types, there are two major forms of diabetes, 
type 1 and type 2. Patients with type 1 diabetes usually have an absolute deficiency of 
insulin secretion, which is caused by destructive lesions of islet beta-cells.  They are 
prone to ketoacidosis and need insulin supplement for survival. Individuals with type 2 
diabetes frequently have an insulin resistance and insufficient insulin secretion. Insulin 
treatment is not required for most of the patients at least at the onset of the disease. The 
most common form of diabetes is type 2, which accounts about 90% of all diabetic 
patients and is the subject of the present study.  
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2.1.2 Diagnostic criteria for type 2 diabetes 
The first widely accepted classification and diagnostic criterion for diabetes was 
proposed by National Diabetes Data Group (NDDG) in 1979 (National Diabetes Data 
Group 1979), which were adopted with minor modification by the WHO in 1980 and 
modified in 1985 (World Health Organization 1980; World Health Orgnization 1985). 
Since then, OGTTs has been considered as the “golden standard test” for diabetes for 
about 20 years, and the glucose cut-off points for a positive test were set at fasting plasma 
glucose (FPG) ? 7.8 mmol/l and/or 2-hour post-challenged glucose (2-hPG) ? 
11.1mmol/l. Impaired glucose tolerance (IGT), defined as FPG < 7.8 mmol/l and 2hPG 
7.8 - 11.1 mmol/l, was first introduced to denote a state which conveys an increased risk 
for diabetes and cardiovascular disease.  
 
In 1997, an expert committee sponsored by American Diabetes Association (ADA) 
proposed new diabetes diagnostic criteria (Expert Committee on the Diagnosis and 
Classification of Diabetes Mellitus 1997) (Table 1).   The major changes include 1) 
lowering the cut-off point of FPG from 7.8 mmol/l to 7.0 mmol/l for diagnosing diabetes; 
2) introducing impaired fasting glucose (IFG), which is defined as FPG of 6.1-6.9 mmol/l, 
as an analogous of IGT; and, 3) recommending FPG, not OGTTs, as the standard 
diagnostic test for epidemiological studies and routine clinical practice. Most of these 
revisions were adopted by WHO Consultation in 1999 (W.H.O Consultation 1999). But 
in the 1999 WHO Consultation, OGTTs was retained as the “golden” standard diagnostic 
test and individuals with IFG were recommended receiving an OGTTs to determine 
glucose tolerance status (Table 1). 
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Table 1. The clinical stages of type 2 diabetes 
Stage of type 2 diabetes Plasma glucose (mmol/l) Evident symptoms  
Normoglycaemia FPG < 6.1 and 2hPG < 7.8 No 
Intermediate 
hyperglycaemia 
Impaired fasting glucose 
FPG 6.1-6.9 and 2hPG <7.8 if 
measured No 
Impaired glucose tolerance FPG < 7.0 and 2hPG 7.8-11.0 
Diabetes 
Undiagnosed FPG ? 7.0 and/or 2hPG ? 11.1 No 
Clinically diagnosed FPG ? 7.0 and/or 2hPG ? 11.1 Yes/no 
 
The difference between ADA and WHO diagnostic criteria evoked a hot debate. Many 
analysis were performed to examine the equivalence of the FPG and 2hPG to predict the 
risk of diabetes, mortality and morbidity from cardiovascular disease, and diabetic 
retinopathy (Barrett-Connor et al. 1998; de Vegt et al. 1998; Harris et al. 1998; de Vegt et 
al. 1999; Hanefeld et al. 1999; Shaw et al. 1999; Shaw et al. 1999; Tominaga et al. 1999; 
Vaccaro et al. 1999; Gabir et al. 2000; Gabir et al. 2000; Hanefeld et al. 2000; Ito et al. 
2000; Larsson et al. 2000; Shaw et al. 2000; Temelkova-Kurktschiev et al. 2000; The 
DECODE Study Group 2001; Unwin et al. 2002; Qiao et al. 2003; The DECODE Study 
Group 2003; Blake et al. 2004; Qiao et al. 2004; Qiao et al. 2004). Both the ADA and 
WHO expert committee had re-evaluated their recommendations several times since 1997. 
In 2003, ADA recommended lowering the FPG cut-off point for IFG from 6.1 mmol/l to 
5.6 mmol/l (The Expert Committee on the Diagnosis and Classification of Diabetes 
Mellitus 2003). However, this was not adopted by the WHO Expert Consultation 
Committee; and, the FPG cut-off point for IFG is remained at 6.1 mmol/l until now 
(WHO/IDF Consultation 2006).  
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In July 2009, an International Expert Committee appointed by the ADA, the European 
Association for the Study of Diabetes (EASD), and the IDF proposed to diagnose 
diabetes by HbA1c?? 6.5 % and high risk individuals by HbA1c 6.0-6.4%, and 
recommended to abandon the FPG and OGTTs as diagnostic test if the resources are 
available (The International Expert Committee 2009). More recently, HbA1c range of 5.7-
6.4% was recommended as identifying individuals with high risk for future diabetes in a 
new ADA report (American Diabetes Association 2010). 
2.2 Epidemiology of type 2 diabetes mellitus 
2.2.1 Prevalence of diabetes 
Over the past few decades, numerous studies had performed in different populations and 
regions all over the world to determine the prevalence of diabetes. The results suggested 
that type 2 diabetes has become one of the major health threats globally. Although it is 
still lower than 4% in communities in traditional societies or in remote areas such as in a 
few of African and Asian countries,  the prevalence of diabetes was about 4% - 10% in 
the adults aged 20-79 years in most regions of the worlds such as in Europe, Australia, 
most of Asian and American countries (Figure 1)  (prevalence of diabetes worldwide, 
http://www.who.int/diabetes/facts/world_figures/en/print.html, Accessed 8 October, 2009) 
(Qiao et al. 2003; The DECODE Study Group 2003; International Diabetes Federation 
2009). In Bahrain, Saudi Arabia, United Arab Emirates, Singapore, Poland, Kirbati, and 
Nauru, the rate even caught 15% - 30% (International Diabetes Federation 2006; 
International Diabetes Federation 2009). Globally, it was estimated that there are about 
285 million adults (aged 20-79 years) with diabetes in the world in 2010, given a 
prevalence of 6.6% (International Diabetes Federation 2009).  
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Figure 1 Prevalence estimates of diabetes (age 20-79 years), 2010. Adopted from 
Diabetes Atlas fourth edition (International Diabetes Federation 2009). 
 
There is an evident increasing trend in the prevalence of diabetes all over the world. As 
summarized in Table 2, this increasing trend can be observed in either developed or 
developing countries. In the United State, for example, the National Health and Nutrition 
Examination Surveys revealed that the prevalence of diabetes was more than doubled 
from 1976 -1980 (5.3%) to 2005-2006 (12.6%). In Greece and Mauritius, the prevalence 
rate increased almost 0.5% each year. As shown by several modeling studies, the 
prevalence of diabetes will keep increasing and the number of diabetic patients will 
increase to 472 millions in 2030 in the world (McCarty  DJ 1994; Amos et al. 1997; Wild 
et al. 2004; International Diabetes Federation 2006; International Diabetes Federation 
2009).   
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Table 2. Secular increasing trend in prevalence of diabetes in different regions  
Region Prevalence (%) Methodology Reference 
United States    
  1976-1980 5.3 Series of cross-sectional population-
based surveys 
(Gregg et al. 2004) 
(Cowie et al. 2009)   1988-1994 7.5 
  1999-2000 8.2 
  2005-2006 12.6 
Western Samoa    
  1978 7.2 Series of cross-sectional population-
based surveys 
(Collins et al. 1994) 
  1991 11.4 
Poole, United Kingdom    
 1983 0.8 Series of surveys based on whole 
population diabetes registration 
(Gatling et al. 1998) 
 1988 0.9 
 1996 1.5 
Netherlands    
 1998 2.2 Series of surveys based on whole 
population diabetes registration  
(Ubink-Veltmaat et al. 
2003)  2000 2.9 
Nord-Trøndelag, Norway    
 1984-1986 2.9 Series of whole population surveys (Midthjell et al. 1999) 
 1995-1997 3.2 
Ontario, Canada    
 1995 5.2 Serious of  surveys based on whole 
population diabetes registration 
(Lipscombe et al. 
2007)  2005 8.8 
Skaraborg, Sweden    
From 1991 to 1995 Increased by 6% 
each year 
Series of surveys based on whole 
population diabetes registration 
(Berger et al. 1999) 
Laxå, Sweden    
  1988-1992 2.8 in women 
2.6 in men 
Serious of surveys based on whole 
population diabetes registration 
(Jansson et al. 2007) 
  1993-1997 4.5 in women 
4.6 in men 
  1998-2001 4.4 in women 
4.5 in men 
Salamis, Greece    
 2002 8.7 Series of cross-sectional population-
based surveys 
(Gikas et al. 2008) 
 2006 10.3 
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Mauritius    
 1987 12.8 Series of cross-sectional population-
based surveys 
(Soderberg et al. 2005) 
 1992 15.2 
 1998 17.9 
Singapore    
 1992 8.6 Series of cross-sectional population-
based surveys 
(Lee 2000) 
 1998 9.0 
 
It has been recognized that the low- and middle-income countries face the greatest burden 
of diabetes. Population based studies in India conducted around 2000 showed that the 
prevalence of diabetes ranged from 6.1% to 19.5% (Shah et al. 1999; Zargar et al. 2000; 
Ramachandran et al. 2001; Gupta et al. 2003; Menon et al. 2006). And, Chennai Urban 
Rural Epidemiology Study (CURES) revealed that the prevalence of diabetes increased 
by 72.3% from 1989 (8.3%) to 2004 (14.3%) (Ramachandran et al. 1992; Ramachandran 
et al. 1997; Ramachandran et al. 2001; Mohan et al. 2006). As called “world diabetes 
capital”, India holds above 50 million people with diabetes (International Diabetes 
Federation 2009), which is the largest number in the world.  
Similarly, the prevalence of diabetes in China also experienced a dramatically increase 
since 1970s (Figure 2) (Shanghai Diabetes Research Cooperative Group 1980; National 
Diabetes Co-operative Study Group 1981; Beijing Diabetes Research Cooperative Group 
1982; Pan et al. 1997; Wang et al. 1998; Dong et al. 2005; Yang et al. 2010). The 
national surveys showed that the prevalence of diabetes increased markedly from  1% in 
the earlier 1980s to 4.5% in the middle 1990s, to 5.5% in the later 1990s, and 9.7% about 
2008 (National Diabetes Co-operative Study Group 1981; Wang et al. 1998; Jia et al. 
2002; Gu et al. 2003; Yang et al. 2010). The prevalence increased more in big cities like 
Beijing and Shanghai than the average increase in the whole country (Shanghai Diabetes 
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Research Cooperative Group 1980; Beijing Diabetes Research Cooperative Group 1982; 
Diabetes research cooperation group of national 'the ninth five' major research plan 2002; 
Jia et al. 2002). IDF predicted that there will be 43.2 million patients in 2010 in China 
(International Diabetes Federation 2009).  
 
 
Figure 2.  The age-standardized prevalence of diabetes in Chinese adults (aged 30 – 74 
years old) from the early 1980s to 2008 in different regions 
* The age of the subjects was 40 – 74 years old. 
Diabetes was defined according to FPG ? 7.8 mmol/l and/or 2hPG ? 11.1 mmol/l in the 
surveys made before 1996; and FPG ? 7.0 mmol/l and/or 2hPG ? 11.1 mmol/l for the 
surveys made since 1999 in Shanghai, Qingdao, and national. 
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2.2.3 Risk determinant of type 2 diabetes mellitus 
It is generally agreed that type 2 diabetes is a poly etiological disorder. The genetic 
background, environmental factors, and the interaction between these all influence the 
development of the disease.  
2.2.3.1 Genetic predisposition 
Type 2 diabetes is a genetic predisposed disease. Individuals with a history of diabetes in 
their parents or siblings were observed to have 2-6 folds high risk for diabetes (Knowler 
et al. 1981; Mitchell et al. 1993; Shaten et al. 1993; Lin et al. 1994; Burchfiel et al. 1995; 
Karter et al. 1999; Bjornholt et al. 2000; Meigs et al. 2000; Sargeant et al. 2000; Thorand 
et al. 2001; Harrison et al. 2003; Valdez et al. 2007). The monozygotic twin concordance 
rate in type 2 diabetes might be 70-80% (Barnett et al. 1981; Newman et al. 1987; Kaprio 
et al. 1992; Matsuda et al. 1994; Ghosh et al. 1996). The prevalence of diabetes is higher 
in certain ethic groups than in others, which also suggests the genetic predisposition 
(Dowse et al. 1990; Lee 2000). More recently, with the advanced technology, the 
genome-wide association studies suggested that dozens of gene variants might associate 
with a high risk for type 2 diabetes (Florez et al. 2007; Zeggini et al. 2007; Gaulton et al. 
2008; Lango et al. 2008; Zeggini et al. 2008; Grant et al. 2009).  
2.2.3.2 Age 
Both the prevalence and incidence of type 2 diabetes increase with age in most of 
populations but the age at peak varies among different ethnic groups. In Chinese  and 
Caucasians, the incidence of diabetes increased with age up to 65-74 years (Blanchard et 
al. 1996; Leibson et al. 1997; Ubink-Veltmaat et al. 2003; Liu et al. 2007), but to 40-50 
years in Pima and Asian Indian (Pavkov et al. 2007; Mohan et al. 2008). After the age at 
peak the incidence and prevalence started to decline. These phenomenon might be caused 
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by the declining glucose utility (Davidson 1979; Ruiz-Torres et al. 1996) and increasing 
mortality after the age at peak. However, it is not clear whether the glucose metabolic 
deterioration accompanied with age is the natural processing of aging or secondary to 
age-related factors such like decreased physical activity and increasing obesity.  
2.2.3.3 Obesity 
Type 2 diabetes is strongly associated with obesity and weight gain. The measurements 
of obesity, such as, body mass index (BMI), waist circumference, waist hip ratio, whole 
or visceral fat mass etc, are positively associated with both the prevalence and incidence 
of diabetes in different populations (Ramachandran et al. 1997; Haffner 1998; Chang et al. 
1999; Goodpaster et al. 2003; Meisinger et al. 2006; Ni Mhurchu et al. 2006). In a US 
study, for instance, each unit increase in BMI was associated with a 12% increased risk 
of diabetes (Ford et al. 1997); and in Chinese, the conversion rate from IGT to diabetes in 
subjects with a high baseline waist circumference was about 3 fold higher than in those 
with a low one (Wat et al. 2001). Weight gain during the follow-up and duration of 
obesity was also positively relate to the onset of diabetes (Everhart et al. 1992; Colditz et 
al. 1995; Wannamethee et al. 1999; Koh-Banerjee et al. 2004; Wannamethee et al. 2005; 
Schienkiewitz et al. 2006). As reported by Everhart et al, in Pima Indians who attained a 
BMI 30 kg/m2, the risk of NIDDM increased from 24.8 per 1,000 person-years in those 
who were obese for <5 years, to 35.2 per 1,000 for obesity of 5-10 years, to 59.8 per 
1,000 for >10 years of obesity (Everhart et al. 1992). Strong evidence from clinical trials 
have confirmed that the weight reduction can prevent or delay the onset of diabetes 
(Tuomilehto et al. 2001; Knowler et al. 2002; Li et al. 2008). The risk for diabetes was 
reduced by 57% in subjects who achieved the weight reduction goal in Finnish Diabetes 
24 
 
Prevention Study (DPS) (Lindstrom et al. 2006). It is noticeable that not all obese people 
develop diabetes, and not all patients with type 2 diabetes are obese at the onset of the 
disease. Given the same degree of obesity defined by either BMI or waist circumference, 
the prevalence of diabetes varied largely among different ethnic groups, which is highest 
in Indians and lowest in Caucasians (Figure 3) (Nakagami et al. 2003; Nyamdorj et al. 
2009). It is still not decided whether diabetes is a consequence of obesity or a parallel 
disorder caused by the same pathogen.  
 
Figure 3. Crude (filled markers) prevalence and estimated (open markers with 95% CIs) 
probability of undiagnosed diabetes according to BMI categories by ethnicity. Adapted 
from the article of (Nyamdorj et al. 2009). 
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2.2.3.4 Physical inactivity 
Peoples with sedentary lifestyle have been consistently shown to have a high risk for 
diabetes in different populations (Villegas et al. 2006; Jeon et al. 2007; Chien et al. 2009; 
Gimeno et al. 2009). Prolonged television watching, as a surrogate of sedentary lifestyle, 
was reported to be positively associated with diabetes risk (Hu et al. 2001; Hu 2003; 
Krishnan et al. 2009). In men, for example, the risk increased progressively to 187% 
higher incidence among those watching TV > 40 hour per week than among those 
spending 0-1 hour per week (Hu et al. 2001); while in women, every 2 hour per day 
increment in television watching was associated with 14% increase in risk of diabetes 
(Hu 2003). Higher level of physical activity is associated with a lower risk of diabetes. 
Results from a number of studies showed a dose-response relationship between levels of 
physical activity and diabetes incidence (Helmrich et al. 1991; Manson et al. 1991; 
Schranz et al. 1991; Manson et al. 1992; Burchfiel et al. 1995; Lynch et al. 1996; 
Haapanen et al. 1997; Folsom et al. 2000; Fretts et al. 2009). And, several clinical trials 
have shown that  moderate physical activity might reduce the progression of IGT to 
diabetes by 30-58% (Eriksson et al. 1991; Pan et al. 1997; Tuomilehto et al. 2001; 
Knowler et al. 2002; Yamaoka et al. 2005; Ramachandran et al. 2006; Li et al. 2008). The 
results of Malmö, Daqing and DPS study even suggested that the protecting effect of 
physical activity was independent of diet and weight loss (Eriksson et al. 1991; Pan et al. 
1997; Hu et al. 2004). There’s no doubt that physical inactivity is an important 
modifiable risk factor of type 2 diabetes. However, it is noticeable that the physical 
activity data based on a questionnaire might be not reliable (Rennie et al. 1998; Shephard 
et al. 2003; Prince et al. 2008). There is still a need to have a valid, accurate and reliable 
measure of physical activity. 
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2.2.3.5 Diet 
For a long time, diet has been considered as an important risk factor for diabetes. Excess 
caloric intake, which results in a positive energy balance, promotes the onset of both 
obesity and diabetes. The westernized dietary pattern, which is rich in saturated fat and 
simple carbohydrate, and scarce in fibres, was suggested to associate with a high risk of 
type 2 diabetes (van Dam et al. 2002; Hodge et al. 2007; McNaughton et al. 2008; Liese 
et al. 2009). On the contrary, a low risk for diabetes was observed in people consuming 
lot of vegetables, fruits, whole grain products, and fish, etc, which are characterized by 
low energy density and low glycemic index but high fibre and unsaturated fat acid 
(Hodge et al. 2004; Liu et al. 2004; Montonen et al. 2005; de Munter et al. 2007; Villegas 
et al. 2008; Patel et al. 2009). The antioxidant such as vitamin C and E, unsaturated fat 
acid, flavonoid etc, might also have protecting effect (Tuomilehto et al. 2004; Montonen 
et al. 2005; Harding et al. 2008; Stote et al. 2008). Diet intervention, plus moderate or 
intensive physical activity have been proved to be effective on the prevention of diabetes 
(Tuomilehto et al. 2001; Knowler et al. 2002; Li et al. 2008). However, since dietary 
pattern depends on the local food resource and the cooking procedure, which is closely 
related to the folk custom, religion, and culture, etc, the results from different studies 
were not always consistent.  
2.2.3.6 Smoking, alcohol consuming and other environmental risk 
factors  
A numerous studies have conducted to determine the association between smoking and 
the risk of type 2 diabetes. The results, however, are not consistent. Recently, a meta-
analysis including 25 perspective studies showed that current smoking associated with a 
44% increased risk of diabetes (Willi et al. 2007). The authors concluded that there is an 
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association between smoking and diabetes; but, whether the association is causal needs to 
be further studied. As for alcohol consumption and the risk of diabetes, a U-shaped 
relationship was found (Baliunas et al. 2009). Compared with abstainers, moderate 
alcohol consumers had about 30% reduced risk of diabetes (Koppes et al. 2005; Beulens 
et al. 2008; Crandall et al. 2009; Imamura et al. 2009). However, high daily consumption 
of alcohol beverage has no protecting effect and might reversely increase the risk for 
diabetes (Beulens et al. 2005; Hodge et al. 2006).  
Urbanization in the developing countries is observed to relate to an increasing prevalence 
of diabetes (King et al. 1998). In China, a consistent urban-rural difference was observed 
in the different surveys (National Diabetes Co-operative Study Group 1981; Pan et al. 
1997; Wang et al. 1998; Gu et al. 2003; Dong et al. 2005). In India, the urban population 
had a 2-5 times higher prevalence of diabetes than the rural (Ramachandran et al. 1999; 
Mohan et al. 2007; Mohan et al. 2008). Although the social-economic status has been 
suggested to modify the risk of diabetes, the affects are different in developing and 
developed regions. In Qingdao city, for example, low socio-economic classes associated 
with a higher prevalence of diabetes in urban areas but a lower prevalence in rural areas 
(Ning et al. 2009).   
2.3 Screening for type 2 diabetes mellitus 
2.3.1 Rational for screening diabetes 
In the WHO guideline of Screening for Type 2 Diabetes, screening was defined as “the 
process of identifying those individuals who are at sufficiently high risk of a specific 
disorder to warrant further investigation or direct action” (World Health Orgnization 
2003). “It (screening) is systematically offered to a population of people who have not 
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sought medical attention on account of symptoms of the disease for which screening is 
being offered and is normally initiated by medical authorities and not by a patient’s 
request for help on account of a specific complaint”.  
The rationales to screen for type 2 diabetes are: 
? Diabetes, which has a rising prevalence world-wide, is now one of the major 
threats to the human health and hinders the social-economic development;  
? In the natural history of diabetes, there is a long, latent, and asymptomatic period 
in which the disease may be detected (Harris et al. 1992; Thompson et al. 1996); 
? Accumulating evidences support that diabetes and its complications are 
preventable with appropriate intervention and/or treatment; 
? There are some screening tools which have been shown to be effective in 
screening diabetes; 
? Although not consistent, there are some evidences showing that screening for 
diabetes might be cost-effective (The C. D. C. Diabetes Cost-Effectiveness Study 
Group 1998; Chen et al. 2001; Hoerger et al. 2004; Hoerger et al. 2007; Gillies et 
al. 2008); 
  
2.3.2 Screening tools and their performance 
The screening tools for diabetes include biochemical tests such as blood glucose, HbA1c 
and urinary glucose test, genetic markers, and risk assessment questionnaires or 
scores, which are briefly reviewed as following.  
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2.3.2.1 Biochemical markers 
 
Urinary glucose test is now not in use where the blood glucose tests are available. 
Although the specificity may be higher than 98%, the sensitivity of urinary glucose test 
was only around 20% to 64% (Davies et al. 1993; Friderichsen et al. 1997; Engelgau et al. 
2000). The renal threshold for re-absorption of glucose varies between individuals, and, 
the presence of glucose in the urine is more likely positive in individuals with a low 
threshold than those with a high threshold. Urinalysis, therefore, has limited use as a 
solitary tool for diabetes screening. 
 
Fasting/Random finger capillary blood glucose test is the easiest and simplest way of 
blood glucose testing. As shown in Table 3, the sensitivities of the capillary blood 
glucose at the optimal cut-off points were about 80% and specificities above 70% in most 
of studies. It is noticeable that the optimal cut-off points varied from 5.0mmol/l to 
7.9mmol/l in different studies. According to Engelgau et al, different optimal cut-off 
points were required to account for the age and postprandial period (Engelgau et al. 1995).  
And, the performance was poor in the Finnish women, with a sensitivity about 40% (Qiao 
et al. 1995). The other concern with the portable blood glucose meter measured readings 
is the accuracy of the result (Sacks et al. 2002). 
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Table 3. Sensitivity and specificity of finger capillary blood glucose in detecting diabetes 
Studies Metabolic 
state 
Diagnostic 
test 
Cut-off point 
(mmol/l) 
Sensitivity (%) Specificity (%) 
(Murphy et al. 1993) Fasting OGTTs 6.7 75.0 93.0 
(Bortheiry et al. 1994) Fasting OGTTs 5.6 In men 89.4, in 
women 85.3 
In men 67.7, in 
women 74.4 
(Engelgau et al. 1995) Random 2hPG 6.1-7.2, depending 
on age  
76.0 – 81.0, 
depending on age 
75.0 – 80.0, 
depending on age 
(Qiao et al. 1995) Random OGTTs  6.2 In men 79.0, in 
women 40.0 
in men 93.0, in 
women 92.0 
(Husseini et al. 2000) Fasting OGTTs 5.0 83.3 79.0 
(Rolka et al. 2001) Random OGTTs 6.7 75.0 88.0 
(Herdzik et al. 2002) Fasting OGTTs 5.8 85.4 94.9 
(Zhang et al. 2005) Random OGTTs 6.7 68.0 89.0 
(Somannavar et al. 2009) Random OGTTs 7.9 78.6 83.9 
 
Glycated haemoglobin A1c (HbA1c) is a good and stable marker of mean blood glucose 
in 4-8 weeks preceding the test. At a value of 5.9% and 6.1%, the sensitivity of HbA1c 
was reported ranging from 76% to 95%, and specificity from 67% to 86% (Tavintharan et 
al. 2000; Tanaka et al. 2001; Bennett et al. 2007). However, in an USA population, it is 
reported that 60% of individuals with screen-detected diabetes based on FPG had a 
normal value of HbA1c (Davidson et al. 1999; Davidson et al. 2001). And the biology 
variation of hemoglobin limits the usage of HbA1c in certain situation such as women in 
pregnancy, individuals with anemia or with abnormal hemoglobin, etc. Also, the assay of 
HbA1c is most expensive.  
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2.3.2.2 Genetic markers 
To establishing a genetic score, which adds up a number of genetic markers, to predict 
diabetes was reported in several studies recently.  It has been shown that genetic score 
may improve the performance over clinical predictors of prevalent diabetes (Lyssenko et 
al. 2008; Meigs et al. 2008; Cornelis et al. 2009; Lin et al. 2009); but, the improvement 
was very limited, and was not found in other studies (Balkau et al. 2008; Schulze et al. 
2009). 
2.3.2.2 Risk assessment questionnaires or scores 
Blood sample is needed for all the blood glucose test and HbA1c. They are invasive, 
relatively expensive, time consuming, and not easy to apply in large population screening 
programs. Dozens of risk scores, risk predicting models or risk assessing questionnaires 
without biochemical measurements have been developed to serve as screening tests 
(Table 4). Most of these were developed and validated in the Caucasians, and a few in 
Indians and other Asians. In general, the areas under the receiver operating characteristic 
curve (AUC) of these risk assessment tools, varied from 70% to 80%. The sensitivities of 
these tools in predicting diabetes were above 70%; but, the specificities were relatively 
low or moderate, about 50-60% at the optimal cut-off points.  
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Table 4. Risk predicting or assessment algorithms in different populations 
Risk assessment scores Risk factors involved Diagnostic test Optimal cut-off 
point (range) 
Area under the 
ROC curve 
(95% CI), % 
Sensitivity (95% CI) at 
the optimal cut-off 
point, % 
Specificity (95% CI) at 
the optimal cut-off 
point, % 
Cambridge risk model 
(Griffin SJ. et al. 2000) 
Age, sex, drug-treated 
hypertension, corticosteroids 
treatment, family history of 
diabetes, BMI and smoking 
2h 75g OGTTs 0.199 80.0 (68-91) 77.3 (54.6-92.2) 72.0 (68.0-76.0) 
Danish Risk score 
(Glumer C. et al. 2004) 
Age, sex, BMI, known history of 
hypertension, diabetes in parents, 
physical activity at leisure time  
2h 75g OGTTs 29(0-60) 80.4 (76.5-83.8) 79.3 (71.4-86.3) 68.7 (67.1-70.3) 
Indian risk score 
(Ramachandran A. et al. 
2005) 
Age, sex, family history of 
diabetes, BMI, waist 
circumference, physical activity 
2h Post load 
blood Glucose 
? 11.1 mmol/l  
21(0-42) 73.2 (70.2-76.1) 76.6 (70.9-81.7) 59.9 (58.5-61.3) 
Indian Diabetes risk 
score (Mohan et al. 
2005) 
Age, waist circumference, 
physical activity, family history of 
diabetes 
2h venous 
plasma glucose 
? 11.1 mmol/l 
60(0-100) 69.8 (66.3-73.3) 72.5 60.1 
Rotterdam study 
(Baan CA. et al. 1999) 
Age, sex, drug-treated 
hypertension, BMI 
2h 75g OGTTs 6(0-22) 68.0 (64-72) 78.0 55.0 
Finnish Risk Score 
(Lindström J. et al. 
2003) 
Age, BMI, waist, drug-treated 
hypertension, physical inactivity, 
daily consuming vegetable, fruit, 
or berries 
Drug-treated 
diabetes 
9(0-20) 85.0 78.0 
(71.0-84.0) 
77.0 
(76.0-79.0) 
DESIR Risk Score Waist circumference, smoking, Clinical Not available 73.3 in men.. - - 
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(Balkau B. et al. 2008) hypertension, family history of 
diabetes 
diagnosed 
diabetes or 
FPG 
(0-5) 83.9 in women 
Thai Risk Score 
(Aekplakorn W. et al. 
2006) 
Age, sex, BMI, waist 
circumference, hypertension, 
family history of diabetes 
2h 75g OGTTs 6 (0-17) 74.0 (71-78) 77.0 60.0 
ADA  recommendation  
(ADA. 2000) * 
Delivery of a baby weighing > 9 
pounds, diabetes in parents or 
siblings,  BMI, age, physical 
activity 
2h 75g OGTTs 10(0-27) 71.0 80.0 34.6 
QDScore 
(Hippisley-Cox et al. 
2009) 
Age, BMI, family history of 
diabetes, smoking, history of 
treated hypertension, history of 
cardiovascular disease, use of 
corticosteroids, social deprivation, 
ethnicity 
Clinically 
diagnosed 
diabetes 
Not available 85.3 (85.0-85.6) 
in women 
83.4 (83.1-83.6) 
in men 
- - 
Oman risk score 
(Al-Lawati et al. 2007) 
Age, waist circumference, BMI, 
family history of diabetes, 
hypertension 
2h post load 
serum glucose 
? 11.1 mmol/l 
10 (0-25) 76(74-79) 62.8(54.3-70.6) 78.2(75.8-80.4) 
German risk score 
(Schulze et al. 2007) 
Waist, height, age, hypertension, 
physical activity, smoking, 
consumption of red meat, whole-
grain bread, coffee and moderate 
alcohol,  
Self-reported 
diabetes 
500(118-983) 82 94.4 66.7 
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SUNSET study 
(Bindraban et al. 2008) 
Ethnicity, BMI, waist 
circumference, resting heart rate, 
family history of diabetes, 
hypertension, history of 
cardiovascular disease 
FPG Not available 
(0-19) 
74 (70-79) in 
Hindustani 
Surinamese, 
79(76-85) in 
African 
Surinamese, 
79 (75-87) in 
Dutch 
 
79,5(69.0-87.3) in 
Hindustani Surinamese, 
78.1(66.6-86.6) in 
African Surinamese, 
71.9(53.0-85.6) in 
Dutch 
47.4(41.0-53.8) in 
Hindustani Surinamese, 
60.7(56.3-65.0) in African 
Surinamese, 
71.2(66.7-75.3) in Dutch 
Canary Islands survey 
(Cabrera de Leon et al. 
2008) 
Age, waist/height ratio, family 
history of diabetes, systolic blood 
pressure, gestational diabetes 
FPG 100 83.7(80.3-87.1)in 
men 
87.4(84.7-90.1) 
in women 
93 in men 
95 in women 
54 in men 
48 in women 
ARIC study  
(Kahn et al. 2009) 
Parental history of diabetes, 
hypertension, race, age, smoking, 
waist circumference, height, 
resting pulse, weight 
FPG, 2hPG or 
clinical 
diagnosis 
38(0-100) 71(69-73) 69 64 
(Bang et al. 2009) Age, sex, family history of 
diabetes, personal history of 
hypertension, obesity, and 
physical activity 
FPG 5(0-9) 79 79 67 
AUSDRISK 
(Chen et al. 2010) 
Age, sex, ethnicity, parental 
history of diabetes, history of high 
blood glucose level, use of 
antihypertension medications, 
smoking, physical inactivity, waist 
circumference 
FPG, 2hPG or 
on treatment of 
diabetes 
12(0-35) 78(76-81) 74.0 67.7 
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3. AIMS OF THE STUDY 
I. To determine the prevalence of type 2 diabetes and secular trend in 
prevalence of diabetes in Chinese adults in  Qingdao, China (Paper I, II, III) 
II. To construct a simple risk score for the presence of undiagnosed diabetes in 
Chinese adults in Qingdao, China (Paper IV) 
III. To evaluate the performance of fasting capillary plasma glucose (FCG) and 
glycated haemoglobin A1c (HbA1c) as screening tests for detecting diabetes 
and pre-diabetes (Paper IV and V) 
IV. To develop a simple risk predicting model for developing diabetes in 
Mauritian Indian adults (Paper VI) 
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4. STUDY POPULATION AND METHODS 
4.1 Study population 
4.1.1 Qingdao Diabetes Survey 2001-2002 
Qingdao city locates in the eastern coastline of China facing Yellow Sea. There are 12 
administration regions in Qingdao city, four urban districts (Shinan, Shibei, Sifang, 
Licang) and 8 rural counties (Laoshan, Chengyang, Jiaozhou, Jimo, Pingdu, Jiaonan, 
Huangdao, Laixi). According to the 2000 census, there were about 7.02 million residents 
living in Qingdao city, about 4.7millions in the rural areas and 2.3 in urban. About 99% 
of the total population are Han Chinese. During the past three decades, the city had 
experienced a rapid urbanization, modernization and industrialization. For example, its 
urban area doubled from 1980 to 2000. The gross domestic product of the city has 
increased from 479.21 million Chinese Yuan ($57.89 million) to 11 500.73 million 
($1389.48 million) during the same period.  
 
From April 2001 to July 2002, a cross-sectional population-based survey for diabetes 
prevalence was conducted in Qingdao. Stratified random cluster sampling was employed 
in the survey to recruit the subjects (Figure 4). Three urban districts (Shinan, Shibei, and 
Sifang) and four rural counties (Jiaonan, Pingdu, Chengyang, and Laoshan) were first 
randomly selected (Dong et al. 2005). Streets and towns were, then, randomly drawn 
from each selected urban and rural area. From the selected streets and towns, street 
blocks and/or villages were then randomly drawn. About 400-800 residents, aged 20-74 
years old and lived in Qingdao for at least 5 years, from each of the street blocks and/or 
villages were randomly selected and invited to participate in the survey. According to the 
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urban to rural ratio of 1:2, 4900 individuals from the urban areas and 10000 from the 
rural areas were randomly selected. In addition, 2 600 urban citizens from one 
community were recruited at the end of the 2001-2002 survey (Gao et al. 2008). Thus, a 
total of 17 500 citizens invited and 14 592 participated the survey, with an overall 
response rate of 83.4%. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. The sampling procedures, participating rates and screening strategies in the 
Qingdao diabetes survey 2001-2002 
 
Rural sample 10 000 
Invited to fasting capillary whole blood glucose test first 
Subjects with FCG ? 6.1mmol/l were invited to 2-hour 
75g oral glucose tolerance tests test
4216 attended 
(response rate 86.0%) 
8220 attended 
(response rate 82.2%) 
469 invited, and 408 attended 
(response rate 87.0%) 
786 invited, and 529 attended 
(response rate 67.3%)  
Urban sample 7 500 
Urban sample 4 900 Urban sample 2 600 
2156 attended 
(response rate 82.9%) 
Invited to 2-hour 75g oral 
glucose tolerance test directly 
Survey 2001-2002 
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4.1.2 Qingdao Diabetes Survey 2006 
The Qingdao Diabetes survey 2006 was aimed to investigate the baseline diabetes 
prevalence before the Qingdao Diabetes Prevention Program (Qd-DPP) was started to 
implement. The prevention project targeted at the entire population of two urban districts 
(Shinan and Shibei) and two rural counties (Jiaonan and Huangdao), which were 
randomly selected. In addition, one urban district (Sifang) and one rural county (Jimo) 
was selected as geographically matched control area. Therefore, the 2006 survey was 
conducted in the six districts mentioned above from February to May 2006. Five 
residential communities (or villages) from each district and 200-250 residents aged 35 -
74 years and lived in Qingdao for at least five years from each residential community (or 
village) were randomly selected. A total of 6 100 individuals were invited and 5 355 
individuals took part in the survey, giving a response rate of 87.8%.  
The two surveys were approved by Qingdao Municipal Health Bureau and local ethics 
committee. Verbal or written consent were obtained from all participants before the 
survey. 
4.1.3 Mauritian Non-Communicable Disease Surveys 
The subtropical island of Mauritius locates in the southwestern Indian Ocean with a 
population about 1.2 million. About 70% of the population are Indians, who were 
migrated from south Asia to the island in 19th centuries. Creoles (28%) and migrant 
Chinese (2%) comprise the rest 30% of the population. Since the World War II, Mauritius 
has experienced industrializations accompanying with a rise in living standards and in the 
prevalence of non-communicable disease (Dowse et al. 1990). 
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In 1987, 1992, and 1998, population-based surveys to inform the prevention and control 
of diabetes and other non-communicable disease were conducted in Mauritius. The target 
population for the surveys was Mauritian adults aged 25-74 years. Two-stage cluster 
sampling schemes based on the existing census was used to randomly select the subjects. 
In 1987, ten randomly selected population clusters (with probability proportional to 
cluster size) were selected. All residents aged 25-74 years from those clusters (about 500-
600 individuals in each cluster) were invited to participate the survey. In 1992 and 1998, 
the same clusters were invited again to re-examinations, and three additional clusters 
were recruited from 1992 and onwards. The response rates of the three surveys were 86%, 
89%, 87% in 1987, 1992 and 1998, respectively.  
 
Four cohorts (1987-1992, 1987-1998, 1987-1992-1998, and 1992-1998) were identified 
according to the dates of baseline survey and dates of re-examinations. Participants with 
both known diabetes and newly diagnosed diabetes at the baseline survey were excluded 
from the current study and incident cases were defined as diabetes diagnosed after the 
baseline survey. After excluding individuals with missing data and participants over 65 
years of age (small numbers of people in this age group), data for analysis were available 
for 1 441 men and 1 653 women aged 25-64 years. 
4.2 Methods 
4.2.1 Qingdao Diabetes Surveys 
4.2.1.1 The demographic and anthropometric measurements 
Similar survey approach was followed by the two surveys except the questionnaire used 
in survey 2006 contains more questions. All eligible individuals were invited to a survey 
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site near their residential communities. Participants were interviewed by trained doctors 
or nurses. Every participant was asked whether he/she had been previously diagnosed 
with diabetes. If the answer was ‘yes’, the glucose level at the diagnosis and the treatment 
for diabetes was checked and reviewed by a doctor. Information about the diabetes in 
parents, siblings and/or offspring was collected with questionnaires. The leisure time 
physical activity during the last 12 months was recorded as: 1) sedentary (no leisure time 
physical activity), 2) light (relaxing walking outside, taiji, etc.), 3) moderate (jogging, 
brisk walking, bowling, social dancing, etc.); and, 4) strenuous (running, gymnastics, 
swimming, badminton, tennis ball, table tennis, etc.).  In the survey 2006, information on 
frequency  and  duration  of  the  exercise  was  also  asked  and  recorded.  Participants  were  
divided into non-smokers including never and ex-smokers, and current smokers if 
smoking daily regardless of the amount and type of smoking for at least half a year.   
 
Height and weight was measured with participants wearing light clothes and without 
shoes. BMI was then calculated by dividing weight (Kg) by height (m) squared. Waist 
circumference was measured at the middle of the rib cage and iliac crest, and the hip 
circumference at the maximal horizontal girth between the waist and thigh. Waist-hip-
ratio (WHR) was calculated by dividing the waist girth (cm) by the hip (cm). Three 
consecutive blood pressure readings, apart for at least 30 second, were taken from the 
right arm of seated subjects, and the average of the three readings was used in subsequent 
data analysis.  
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4.2.1.2 Screening strategies for undiagnosed diabetes in the 2001-2002 
survey 
Two screening strategies for detecting undiagnosed diabetes were applied in the 2001-
2002 survey (Figure 4). From April 2001 to February 2002, two-step screening strategies 
using FCG test as first line screening, followed by a standard 2-hour 75g OGTTs to those 
with a FCG ? 6.1mmol/l, was applied in 12 436 participants who did not have a prior 
history of diabetes. From March to July of 2002, standard 2h 75g OGTTs were 
administrated directly to all participants (n = 2156) (Figure 4).  
4.2.1.3 Screening test for undiagnosed diabetes in the 2006 survey 
The standard 2h 75g OGTTs was administrated to all participants (n = 5355). FCG was 
also tested in the same morning in all participants in order to compare the data with those 
collected in 2001-2002 survey.  
4.2.1.4 Laboratory assays 
Blood samples were collected locally. All participants were instructed not to eat after 
20:00 h and not to drink after 22:00 h in the night before the blood sampling. In next 
morning, fasting blood samples were collected from 07:00 to 09:30 h and post-load 
samples from 09:00 to 11:30 h. FCG were determined in the same morning immediately 
after the fasting blood sample was taken using Lifescan one Touch II glucose testing 
system in the survey 2001-2002, and, Bayer Brio Meter Kit in the survey 2006. The 
assays of plasma glucose and lipids of the two surveys were done in the central 
laboratory of Hiser Medical Centre. Plasma glucose was determined by the glucose 
oxidase method, and fasting plasma triglycerides, total and high density lipoprotein 
cholesterol (HDL-c) with enzymatic method. In the 2001-2002 survey, fasting and 2-
hour serum insulin was measured in a sub-sample with radioimmunoassay (ket 
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purchased from North Biotechic Institute, Beijing); while in 2006 survey, serum insulin 
was measured with chemiluminescent immunoassay (Abbott, Axsym, USA). 
Homeostasis model assessment insulin resistance (HOMA IR) index was calculated as: 
fasting insulin (?IU/l) multiplied by fasting glucose (mmol/l), divided by 22.5. HbA1c 
was determined in the participants of 2006 survey with Olympus AU640 Automatic 
analyzers using immunoturbilimetric assay (Tina-quant Hemoglobin A1c, BM/Hitachi 
reagent kit, Roche, Germany). 
4.2.2 Mauritian Non-Communicable Disease Surveys 
The same study protocol was used for all surveys in Mauritian. All eligible residents were 
invited to attend a survey site after an overnight fast. Trained nurses administered a 
questionnaire to all participants, in which the self-reported family history of diabetes in 
first-degree relatives (parents, sibling and/or offspring), smoking and alcohol habits, 
treatment for hypertension, prior history of diabetes, years of full-time education, and 
monthly household income of the family were recorded. Height and weight was 
measured in light clothing without shoes, and body mass index (BMI) was calculated. 
Waist circumference was measured as the minimum circumference between iliac crest 
and the lowest rib. 
 
All subjects had fasting blood samples taken, and plasma total cholesterol, triglyceride, 
and high density lipoprotein cholesterol (HDL-c) were measured by enzymatic methods. 
Standardized 75-g OGTTs was administered to all participants not taking diabetes 
medication. Fasting and 2-hour post-challenge plasma glucose was determined on-site in 
1987 and 1992 using YSI glucose analyzers (Yellow Springs Instruments, OH, USA) 
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within 3 hours of collection with quality controls measured several months later in 
Newcastle upon Tyne, UK, at the reference laboratory. In 1998, plasma sample was 
frozen immediately and glucose was measured within 4 months in Newcastle upon Tyne, 
UK. The 1998 glucose values were adjusted to account for delay in analysis of blood 
samples using an equation (adjusted glucose = 0.0288 + 1.037 × measured glucose) based 
on the difference between on-site values and quality controls from the 1987 and 1992 
surveys (Soderberg et al. 2004).  
 
Data pertaining to occupational and leisure physical activities over the past year were 
collected by interview-administered questionnaire. Using a prepared guideline, 
occupational and leisure physical activity level was categorized into four patterns: 
sedentary (1), light (2), moderate (3), and heavy (4) (Dowse et al. 1991). Occupational 
activity was graded as ‘sedentary’ for office workers and ‘heavy’ for building laborers, 
while leisure activity varied from ‘sedentary’ for those house-bound with no regular 
outside activity to ‘heavy’ for individuals who undertook vigorous sports (e.g. tennis, 
volleyball, jogging, etc.) for 30 min or more on at least 3 days per week.  Since there 
were few participants with ‘heavy’ physical activity, their data were pooled with those 
reporting ‘moderate’ physical activity in the current study.  
4.3 Diagnosis of diabetes and pre-diabetes 
Previously diagnosed diabetes was made if a prior history of diabetes was reported and 
confirmed by a doctor according to previous fasting plasma glucose (FPG) level of  ? 7.0 
mmol/l and/or information on treatment regardless of the FPG level.  
44 
 
Those without a prior history of diabetes were classified according to the 2006 WHO 
/IDF criteria for diabetes (WHO/IDF Consultation 2006). Undiagnosed diabetes was 
defined by a FPG level of ? 7.0 mmol/l and/or 2h PG of ? 11.1mmol/l. Individuals who 
had a FPG of 6.1-6.9mmol/l and/or 2hPG of 7.8-11.0 mmol/l were defined as impaired 
fasting glucose (IFG) and/or impaired glucose tolerance (IGT). Both IFG and IGT were 
considered as pre-diabetes in the current study. 
4.4 Statistical analyses 
4.4.1 The calculation of prevalence in Qingdao Diabetes Surveys 
The prevalence of previously diagnosed diabetes was calculated by dividing the number 
of subjects with confirmed history of diabetes by the total number of participants 
returning valid questionnaire. The prevalence of undiagnosed diabetes was calculated in 
two different ways among individuals without a prior history of diabetes. Because only 
subjects with FCG ? 6.1 mmol/l were invited to have OGTTs from April 2001 to 
February 2002, the prevalence of undiagnosed diabetes was calculated according to the 
equation: (total number invited to the OGTTs × prevalence [%] of diabetes in the 
participants attending in the OGTTs) / number of the entire study population without 
diagnosed diabetes. Among the participants who participated the survey from March to 
July in 2002 and from February to May in 2006, the prevalence of undiagnosed diabetes 
was calculated as number of diabetes detected by the OGTTs divided by the total number 
of participants attending in the OGTTs. According to the 2000 census in Qingdao the 
age- and sex-standardized prevalence was calculated for population aged 35 to 74 years. 
The Chi-square test was used to test the difference in prevalence among age groups, sexes 
and areas. 
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4.4.2 The development and validation of the diabetes risk score in 
Chinese 
The risk score was derived based on the data of the Qingdao diabetes survey 2001-2002. 
Candidate risk factors including age, family history of diabetes, smoking status, physical 
activity, BMI, waist circumference, and systolic blood pressure were fitted into a Logistic 
regression model one by one. Those came out to be statistically significant (p<0.05) in 
the univariate analysis were further fitted into the final multivariate Logistic regression 
model using backward stepwise LR method. The Hosmer-Lemeshow test was used to 
examine how well the predicted prevalence matches the observed prevalence. A large p-
value indicates a good match. The net reclassification improvement (NRI) was also 
calculated according to Pencina MJ et al to quantify the improvement in the right 
reclassification of models (Pencina et al. 2008). According to the estimated probability of 
having diabetes, individuals were classified into categories of ? 10.9%, 11.0-15.2%, 15.3-
19.7% and ? 19.8% in men and of ? 7.5%, 7.6-11.9%, 12.0-17.7% and ? 17.8% in 
women. These categories were used in NRI analysis. The log-likelihood ratio test was 
performed to check whether adding a variable to a model will improve the model 
prediction. Beta coefficients derived from the final multivariate Logistic regression 
model was used to calculate the diabetes risk score.  
 
The validation of the risk score derived based on the data of the survey 2002 was 
examined in the population of the 2006 survey. Receiver operating characteristic curve 
(ROC) was plotted for the score against the presence of the undiagnosed diabetes. The 
optimal cut-off point was identified as the co-ordinate closest to the y intercept (0, 1) of 
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the ROC curve, and it is at this point that the sum of the sensitivity and the specificity is 
maximum. C-statistics was used to compare AUC. 
4.4.3 The development and validation of the diabetes risk predicting 
models in Mauritian Indians 
Since the diabetic status was only assessed in each of the three surveys in five-years 
interval approximately, the actual date of a diagnosis of diabetes was not available. 
Therefore, the Cox proportional hazard model for interval censored data using age as the 
time scale was applied to estimate the regression coefficients of the risk factors and the 
baseline hazards (Carstensen 1996) with assumption that diabetes were developed just 
prior to the follow-up survey. The R program (version 2.5.1) (http://www.r-project.org/) 
was used to establish the Cox regression models for interval censored data.  
 
Data from half of the participants were randomly selected to establish the risk predicting 
models and the remaining data were used to assess the validation. Due to the small 
sample size, the data derived for certain age group in women was less reliable as 
indicated by a wide confidence interval. Nevertheless the risk predictors identified were 
similar for men and women. To increase the statistical power, data from men and women 
were pooled together when developing the predicting model, where sex was considered 
as a co-variable. However, the predicting model was assessed separately for men and for 
women to see whether the model derived based on the whole study population is valid 
when it is applied to men or to women separately.  
 
The potential risk predictors such as BMI, waist, family history of diabetes, and FPG etc. 
were first tested in separate models adjusting for sex and cohort. The final full model was 
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fitted with risk factors which were statistically significant (P < 0.05) in each of the 
separate models. In order to get a simple prediction model based on only demographic 
and physical examination data, FPG, systolic blood pressure and triglycerides, which 
require blood sampling and clinical measure were excluded from the simple model. The 
probabilities of diabetes (given the age at entry) were calculated with regression 
coefficient and baseline hazard derived from the simple model and plotted in the risk 
chart. Akaike’s information criterion (AIC) values, a measure of goodness-of-fit of the 
regression models, were calculated for each of the models (Clayton et al. 1993)]. The 
lower ACI value indicates a better fit to the data.  
 
To evaluate the discriminatory ability of the models in the prediction of developing 
diabetes, receiver operating characteristic curves (ROC) were plotted using estimates of 
the simple model and the simple model plus FPG; C-statistics were used to compare the 
areas under the receiver operating characteristic curves (AUC) using STATA 8.2 (Stata 
Corporation, College Station, Texas, USA).  
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5 RESULTS 
5.1 Baseline characteristics of the participants of the Qingdao 
diabetes surveys 
The population mean of BMI, waist and hip circumference, blood pressure, glucose, 
lipids and the proportion of individuals who were current smoker, had a positive family 
history of diabetes and different levels of physical activity was calculated in the 
participants aged 35 – 74 years old and presented in Table 5. In both surveys, the urban 
participant reported more often a positive family history of diabetes than the rural 
individuals did.  In the survey 2001-2002, participants in the urban areas were more 
obese, and practised less vigorous physical activity than those in the rural areas. In the 
survey 2006, the urban men tended to be more obese than the rural men, but the urban 
women were slender than the rural women. And, rural residents were more sedentary than 
urban individuals. The prevalence of current smoker was higher in rural participants than 
in urban in both surveys.  
 
Compared with the participants in the survey 2001-2002, the subjects of the survey 2006 
had a higher level of blood pressure, blood glucose, and a lower physical activity levels 
(Table 5). BMI, waist and hip circumference were larger in 2006 survey than in 2001 in 
the rural participants, whereas this was not observed in the urban. The prevalence of 
current smoker was significantly higher in male subjects of the survey 2006 than in those 
of the survey 2001-2002.
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Table 5. Baseline characteristics of the participants (aged 35-74 years) who had no a prior history of diabetes 
 Survey 2001-2002 Survey 2006 P value between 
surveys in urban 
P value between 
surveys in rural  Urban Rural Urban Rural 
Men       
No of subjects 2048 2331 707 1007 - - 
Age, years 53.8(53.3-54.2) † 50.5(50.0-50.9)  51.2(50.4-51.9) 50.1(49.4-50.7) < 0.001 0.32 
Body mass index, kg/m2 25.9(25.7-26.0) † 23.9(23.8-24.1) 25.8(25.6-26.1) 25.6(25.4-25.8) 0.70 < 0.001 
Waist, cm 89.3(88.9-89.7) † 84.4(84.0-84.8)  88.9(88.2-89.6) ‡ 86.8(86.2-87.4) 0.36 0.02 
Hip, cm 99.4(99.1-99.7) † 96.8(96.4-97.1)  100.1(99.6-100.6) ‡ 98.0(97.5-98.4)  0.01 < 0.001 
Systolic blood pressure, mmHg 129(128.4-130.0) 128(127.5-129.1)  134(132.9-135.7) 136(134.7-137.1) < 0.001 < 0.001 
Diastolic blood pressure, mmHg 84(83.3-84.4) † 82(81.7-82.7)  88(86.9-88.6) 87(86.5-88.1) < 0.001 < 0.001 
Fasting capillary glucose, mmol/l  5.32(5.27-5.37) † 5.12(5.08-5.16)  5.68(5.60-5.75) ‡ 6.06(5.99-6.13)  < 0.001 < 0.001 
Fasting plasma glucose, mmol/l  5.47(5.39-5.56) * - 6.14(6.04-6.25) ‡ 5.24(5.16-5.31)  < 0.001 < 0.001 
2-hour post-load glucose, mmol/l  5.90(5.71-6.09) * - 7.07(6.83-7.31) ‡ 6.38(6.23-6.53)  < 0.001 < 0.001 
Physical activity (%)     < 0.001 < 0.001 
Sedentary 23.6 23.7 51.6† 77.1 - - 
Light 58.3 52.6 34.9 17.1 - - 
Moderate or intensive 18.0† 23.7 13.6† 5.9 - - 
Family history of diabetes, (yes, %) 14.5† 3.7 19.5 11.4 < 0.001 < 0.001 
Current smoker (%) 40.6† 47.6 47.1 58.3 < 0.001 < 0.001 
Women       
No of subjects 2874 3601 1259 1443   
Age, years 53.2(52.9-53.6) † 50.4(50.1-50.7)  50.3(49.8-50.9) ‡ 48.9(48.3-49.4)  < 0.001 < 0.001 
Body mass index, kg/m2 25.8(25.7-26.0) † 24.7(24.6-24.8)  25.6(25.4-25.7) ‡ 26.3(26.1-26.4)  0.03 < 0.001 
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Waist, cm 83.7(83.4-84.1) † 82.7(82.3-83.0)  81.6(81.1-82.0) ‡ 83.6(83.1-84.1)  < 0.001 0.003 
Hip, cm 99.2(98.9-99.5) † 97.3(97.1-97.6)  99.5(99.1-99.9) 99.1(98.7-99.5) 0.32 < 0.001 
Systolic blood pressure, mmHg 128(127.3-128.7) 128(127.3-128.7)  131(129.7-131.8) ‡ 136(135.5-137.7) < 0.001 < 0.001 
Diastolic blood pressure, mmHg 82(81.5-82.3) † 80(79.5-80.3)  84(83.4-84.7) 85(84.5-85.8) < 0.001 < 0.001 
Fasting capillary glucose, mmol/l  5.37(5.32-5.42)  5.33(5.29-5.36) 5.61(5.55-5.67) ‡ 6.21(6.14-6.28)  < 0.001 < 0.001 
Fasting plasma glucose, mmol/l  5.47(5.42-5.53) * - 5.85(5.79-5.91) ‡ 5.30(5.24-5.37)  < 0.001 - 
2-hour post-load glucose, mmol/l  6.05(5.93-6.18) * - 7.13(6.99-7.28) 6.86(6.73-7.00)  < 0.001 - 
Physical activity (%)     < 0.001 < 0.001 
Sedentary 20.5 24.6 53.8‡ 77.8 - - 
Light 63.7 53.5 35.2 17.6 - - 
Moderate or intensive 15.8† 21.9 11.0‡ 4.6 - - 
Family history of diabetes, (yes, %) 15.8† 3.3 25.5‡ 11.6 < 0.001 < 0.001 
Current smoker (%) 1.8 2.2 1.6 2.8 0.70 0.25 
Data are mean (95% CI) or percentage.  
*Data for 661 urban men and 1130 urban women attending oral glucose tolerance tests directly in the 2001-2002 survey. 
p < 0.005,  † for the difference between the subjects of the urban areas and of the rural in the survey 2001-2002; ‡ for the 
difference between the subjects of the urban areas and of the rural in the survey 2006 
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5.2 Prevalence of diabetes and pre-diabetes in Qingdao city 
5.2.1 Prevalence in the survey 2001-2002 (Paper I and II) 
With the two-step screening approach, the age-standardized prevalence of diabetes was 6.0% 
(4.0% for undiagnosed and 2.0% for previously known diabetes) in the adults aged 20 to 74 
years. The prevalence of diabetes, both previously undiagnosed and known, increased with aging 
(Figure 5). It reached 10% in subjects older than 50, and about 89% of the cases were 40 to 74 
years old. The mean age of those with previously undiagnosed diabetes was 54.6?10.8 (rural 
53.8?11.2, urban 55.6?10.2).  
Figure 5. Prevalence of diagnosed (a) and previously undiagnosed diabetes (b) in men and 
women in Qingdao city, China. P<0.05, * for difference between the men and women in the 
same age stratum. 
 
Men tended to have a higher prevalence of known diabetes than women, whereas, prevalence of 
previously undiagnosed diabetes was higher in women than in men, particularly in elder 
population (50-74 years old). The prevalence of diabetes was higher in urban men than in rural 
men (9.2% vs 5.1%, X2=14.4 and 20.0, df=1, p<0.05). The proportion of previously undiagnosed 
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cases among all diabetic subjects was higher in the rural than in the urban residents (70.4% vs 
58.0%, X2=15.4, df = 1, p<0.05).  
 
The age-standardized prevalence of diabetes and pre-diabetes in 2156 urban participants, who 
underwent OGTTs directly, was 8.9% (6.5% for undiagnosed and 2.4% for previously known 
diabetes) and 13.8%, respectively. The prevalence of diabetes and pre-diabetes increased with 
aging and above 10% in participants older than 40 years. There’s no significant difference in the 
prevalence of diabetes (10.8% VS 7.8%, X2 = 3.38, df=1, p = 0.07) and pre-diabetes (16.1% VS 
12.4%, X2 = 0.08, df=1, p = 0.78) between men and women. 
5.2.2 Prevalence in the survey 2006 (paper III) 
The age-standardized prevalence of diabetes and pre-diabetes was 16.0% (10% for undiagnosed 
diabetes and 6.0% for diagnosed diabetes) and 23.9% in the population aged 35 to 74 years, 
respectively. Similar as in the 2001-2002 survey, the prevalence of diabetes and pre-diabetes 
raised with aging; and higher in the urban participants than in the rural (Table 6). The prevalence 
did not differ between men and women, and the proportion of undiagnosed diabetes was similar 
in rural and in urban areas (60.8% vs 64.4%, df =1, X2=0.96, P=0.33). 
5.2.3 Increasing secular trends in prevalence of diabetes (Paper III) 
Applying the same diagnostic approach and in the same age range (35-74 years), the age- and 
sex-specific prevalence of diabetes increased remarkably in the population of survey 2006 than 
in the survey 2001-2002 (Table 6 and Table 7). According to the results of the direct OGTTs test, 
the age-standardized prevalence was 12.2% in the urban population (aged 35-74 years) in survey 
2001-2002,  whereas they were18.8% in the urban (X2 = 32.2, df = 1, p < 0.001) and 14.1% (X2 = 
9.1, df =1, P = 0.003) in the rural populations in 2006, a significant increase from 2002 to 2006. 
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The prevalence of pre-diabetes was also higher in both men and women in the survey 2006 than 
in 2001-2002 in each age band (Table 6). The age-standardized prevalence of pre-diabetes in the 
urban population was almost doubled from 2002 to 2006 (28.7% in 2006 vs 15.4% in 2002, 
X2=96.6, df = 1, P < 0.001). 
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Table 6. The age- and sex-specific prevalence of pre-diabetes, undiagnosed, and previously diagnosed diabetes based on one-step 
standard 2-h 75g oral glucose tolerance test results in participants aged 35-74 years 
  Survey 2001-2002  Survey 2006 
 No of subjects Prevalence (%)    No of subjects Prevalence (%)    
 
 Pre-diabetes 
Undiagnosed 
diabetes 
Diagnosed 
diabetes 
 Pre-diabetes 
Undiagnosed 
diabetes 
Diagnosed 
diabetes 
Urban Men         
35-44 112 11.6 6.3 3.3 222 32.0 11.3 1.4 
45-44 204 12.7 11.3 4.3 232 33.3 13.7 5.7 
55-64 226 20.8 11.9 6.4 158 27.6 12.8 11.6 
65-74 159 23.3 12.6 7.5 95 27.2 21.4 19.8 
Age-standardized - 15.1 9.6 4.7 - 31.0 13.6 6.8 
Urban Women         
35-44 197 9.1 5.1 0.5 400 24.1 6.2 0.8 
45-44 403 16.4 6.7 3.3 487 26.3 9.5 3.5 
55-64 379 21.9 12.7 6.5 248 36.6 17.1 12.7 
65-74 206 24.3 11.2 6.0 124 28.7 18.9 20.4 
Age-standardized - 15.6 7.7 3.1 - 27.5 10.8 6.4 
Rural Men*         
35-44 - - - - 363 16.8 6.1 2.8 
45-44 - - - - 317 15.4 11.9 6.5 
55-64 - - - - 214 24.5 11.3 4.8 
65-74 - - - - 113 24.6 11.5 8.0 
Age-standardized - - - - - 18.7 9.5 4.9 
Rural Women*         
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35-44 - - - - 569 17.7 2.2 1.6 
45-44 - - - - 490 21.6 9.8 5.1 
55-64 - - - - 269 28.0 12.6 10.4 
65-74 - - - - 115 21.5 16.3 15.3 
Age-standardized - - - - - 21.1 8.2 6.1 
* There were no direct OGTTs administrated to the rural subjects in the survey 2001-2002, and they could not be classified.   
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Table 7. The age- and sex-specific prevalence of undiagnosed and previously diagnosed diabetes based on two-step screening 
approach* in participants aged 35-74 years 
 Survey 2001-2002  Survey 2006 
 No of subjects Prevalence (%) No of subjects Prevalence (%) 
 
Undiagnosed 
diabetes 
Diagnosed 
diabetes 
Undiagnosed 
diabetes 
Diagnosed 
diabetes 
Urban Men       
35-44 334 5.4 1.8 222 7.6 1.9 
45-44 467 7.8 3.6 232 8.6 5.6 
55-64 372 6.4 6.8 158 9.8 11.6 
65-74 280 6.4 12.3 95 15.8 18.7 
Age-standardized - 6.4 4.6 - 9.3 6.9 
Urban Women       
35-44 417 2.5 0.7 400 4.0 1.0 
45-44 634 6.8 2.0 487 5.4 3.5 
55-64 423 8.2 6.0 248 11.2 12.4 
65-74 332 11.1 11.7 124 9.0 18.4 
Age-standardized - 5.9 3.6 - 6.3 6.2 
Rural Men       
35-44 710 2.0 1.1 363 3.6 2.8 
45-44 777 3.7 3.3 317 10.3 6.5 
55-64 481 5.2 4.1 214 7.7 4.8 
65-74 312 5.0 4.2 113 9.0 8.0 
Age-standardized - 3.5 2.7 - 7.0 4.9 
Rural Women       
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35-44 1193 3.7 0.6 569 1.7 1.6 
45-44 1282 7.3 1.6 490 8.3 5.1 
55-64 687 8.9 4.2 269 9.7 10.4 
65-74 523 10.1 5.5 115 13.3 15.3 
Age-standardized - 6.6 2.2 - 6.7 6.1 
 
* OGTTs administrated to those with fasting capillary plasma glucose (FCG) ? 6.1mmol/l, and the classification made based on the 
OGTTs results only.
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5.3 Performance of FCG and HbA1c as a screening test for diabetes in 
Chinese adults (paper IV and V) 
 
FCG 
There were 3948 participants (1555 males) in the survey 2006 who had both FCG and OGTTs 
results, but no prior history of diabetes. Based on the data of these subjects, the AUC in 
predicting undiagnosed diabetes was 76.9% (72.9-80.9%) in men and 76.0% (72.2-79.8%) in 
women for FCG (Figure 6). They were 62.4% (59.0-65.7%) in men and 63.2% (60.5-65.8%) in 
women in predicting pre-diabetes. The sensitivity and specificity of FCG at different cut-off 
point for predicting diabetes was presented in Table 10.  
Validation of two-step screening strategy using FCG as first line screening test 
The two-step screening approach, i.e. using FCG test as first line screening and followed by a 
standard 2-hour OGTTs, missed both undiagnosed diabetes and pre-diabetes who would have 
been detected by OGTTs. In the participants of the Qingdao survey 2006, for example, there 
were about 670 men (42.5%) and 849 (34.7%) women with a FCG ? 6.1mmol/l. Among them, 
the number of undiagnosed diabetes was 140 in men and 174 in women. However, the total 
number of undiagnosed diabetes in the entire study population defined by the direct OGTTs was 
193 in men and 253 in women. The two-step screening approach, thus, missed about 27.5% 
([193 – 140] / 193) of undiagnosed diabetes in men and 32.3% in women. The corresponding 
figures for pre-diabetes were 48.1% in men and 46.2% in women, respectively. When FCG of 
5.5 mmol/l was set as the cut-off point for the first line screening, there were still 10.5% men and 
13.1% women with undiagnosed diabetes unidentified (26.7% men and 26.2% women for pre-
diabetes).  
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HbA1c 
A total of 3132 participants in the 2006 survey had both HbA1c and OGTTs results. In these 
participants, the AUC of HbA1c in predicting undiagnosed diabetes was 68.0% (63.6-72.4%) in 
men and 67.5% (63.6-71.4%) in women (Figure 6). The optimal cut off point was 5.90% in men 
and 5.44% in women (Table 10). The HbA1c values did not distinguish between people with pre-
diabetes from those who were normal because the AUC was about 50% in both men and women. 
Comparison between FCG and HbA1c 
This was done in 2332 participants in the survey 2006, who have no missing data in HbA1c, FCG, 
FPG, 2hPG, BMI, triglyceride, and high density lipoprotein cholesterol. The AUC was lower for 
HbA1c than for FCG for detecting undiagnosed diabetes (0.67 vs. 0.77, P < 0.01, in men; and 
0.67 vs. 0.75, P < 0.01, in women) and pre-diabetes (0.47 vs. 0.64, P < 0.001, in men; and 0.51 
vs. 0.65, P < 0.001, in women). For undiagnosed diabetes plus pre-diabetes the AUC for HbA1c 
were also lower than that for FCG (0.53 vs. 0.69, P < 0.001, in men; and 0.55 vs. 0.68, P < 0.001, 
in women). At the optimal HbA1c cut-off point of 5.6% for undiagnosed diabetes, the sensitivity 
was 64.4% in men and 62.3% in women, whereas they were 72.0% and 65.1% at the optimal 
FCG cut-off point of 6.3 mmol/l for men and 6.6 mmol/l for women. 
 
5.4 Risk score and its performance in Chinese (Paper IV) 
Development of risk score 
Age, waist circumference, and diabetes in parents and/or siblings were independently associated 
with the presence of undiagnosed diabetes in both men and women (Table 8).  Waist 
circumference appeared to be a strong modifiable risk factor for type 2 diabetes in this study 
population as shown by the log likelihood ratio test. Systolic blood pressure (SBP) was 
associated with the presence of undiagnosed diabetes in females only, but SBP did not improve 
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the model reclassification (net gain in reclassification proportion of 0.023 in men [p = 0.75] and 
0.015 in women [p = 0.89] calculated using NRI) when it was added to the model with age, 
family history of diabetes and waist circumference. SBP was thus not included in the final model 
in order to make the final model similar in women as in men and easy to apply by a lay person. 
Hosmer-Lemeshow test showed the predicted risk of the final model matched up well with the 
observed risk (X2 = 6.23, p = 0.62 in men; and X2 = 10.36, p = 0.24 in women). Based on the 
beta coefficient of the final model (Table 8), the risk score was constructed and shown in the 
Table 9.  The optimal cut-off point of the risk score for undiagnosed diabetes was 17 in men and 
14 in women. Among all the participants with undiagnosed diabetes in the survey 2002, 97.5% 
of men and 86.8% of women had a risk score ? 14; and 85.0% in men and 69.5% in women had 
a score ? 17, respectively.    
 
Validation of the risk score 
The risk score derived based on the data of the survey 2002 was evaluated by applying the score 
to the population of the 2006 survey. The ROC curves for the risk score, the FCG and HbA1c 
tests were plotted in Figure 6 and the discrimination of the score was compared with other two.  
The score gave an AUC of 63.5% (95% CI, 59.1-67.9%) in men and 68.9% (63.6-72.4%) in 
women for detecting undiagnosed diabetes, which was slightly lower than that of the FCG test (p 
< 0.001) but not different from that of the HbA1c (p > 0.20).  Given the same sensitivity, the 
specificities of the FCG test were highest; however, there was no significant difference between 
the HbA1c and the risk score (Table 10).   
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The AUC of the risk score for pre-diabetes were 61.2% (57.9-64.5%) in men and 63.2% (60.7-
65.7%) in women. At a cut-off point of ? 14, the sensitivity and specificity of the risk score to 
screen pre-diabetes were 85.6% (83.9-87.4%) and 21.1% (19.0-23.1%) in men, and 75.5% (73.8-
77.2%) and 43.6% (41.6-45.6%) in women, respectively.  
 
Comparison of the Chinese risk score with other existing ones 
We applied also other previously published scores which were derived from other populations to 
our study population of the 2006 survey. Eight such risk scores (Baan et al. 1999; American 
Diabetes Association 2000; Griffin et al. 2000; Lindstrom et al. 2003; Glumer et al. 2004; 
Ramachandran et al. 2005; Aekplakorn et al. 2006; Balkau et al. 2008) were applicable to the 
data and thus, validated. The performance of these scores was poorer in Chinese population of 
the 2006 survey than in their original populations as shown by the lower AUCs (Table 11). None 
of the existing risk scores had a significantly larger AUC than the simple risk score developed in 
this study. 
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Table 8.  The risk factors and the beta coefficient derived from the Logistic regression analyses 
based on the data of Qingdao 2001-2002 survey 
 Univariate model Final model 
 B coefficient (SE) Odds ratio (95%CI) B coefficient (SE) Odds ratio (95%CI) 
Men     
Age (year) 0.03(0.01) 1.03(1.01-1.05) 0.03(0.01) 1.03(1.01-1.05) 
BMI (Kg/m2) 0.06(0.03) 1.06(1.01-1.12) -  
Waist (Chinese Chi) * 0.12(0.03) 1.12(1.05-1.20) 1.09(0.33) 2.98(1.56-5.68) 
Systolic blood pressure, 
(mmHg) 
0.01((0.00) 1.01(1.00-1.02) - - 
Diabetes in parents or siblings 0.60(0.23) 1.82(1.16-2.84) 0.73(0.24) 2.07(1.30-3.29) 
Leisure time physical activity 
(moderate) 
- 1 - - 
Sedentary 0.16(0.32) 1.18(0.63-2.20) - - 
Light 0.50(0.27) 1.66(0.97-2.83) - - 
Current smoker (vs non-
smoker) 
-0.09(0.21) 0.91(0.60-1.38) - - 
Women     
Age (year) 0.05(0.01) 1.05(1.03-1.06) 0.04(0.01) 1.04(1.02-1.06) 
BMI, (Kg/m2) 0.07(0.02) 1.07(1.03-1.11) - - 
Waist, (Chinese Chi)* 0.14(0.03) 1.15(1.09-1.20) 0.86(0.28) 2.36(1.35-4.12) 
Systolic blood pressure 
(mmHg) 
0.02(0.00) 1.02(1.02-1.03) - - 
Diabetes in parents or siblings 0.51(0.19) 1.67(1.15-2.42) 0.82(0.20) 2.27(1.53-3.38) 
Leisure time physical activity 
(moderate) 
- 1 - - 
Sedentary -0.05(0.28) 0.95(0.55-1.65) - - 
Light 0.10(0.21) 1.11(0.73-1.69) - - 
Current smoker (vs non-
smoker) 
0.60(1.04) 1.83(0.24-14.18) - - 
 *1 Chinese Chi ? 33 cm. 
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Table 9. The risk score based on the age, sex, waist girth and diabetes in parents or siblings 
Waist (Chinese Chi *)     
Men Score   Women Score 
?2.3 1 ? ?2.0 1 
2.4-2.6 4  2.1-2.3 3 
2.7-2.9 8  2.4-2.6 6 
?3.0 12 ? ?2.7 9 
Age (years) Score  
?35 1    
36-45 3    
46-55 6    
56-65 9    
?65 12    
Diabetes in parents and/or siblings Score 
Negative 1 
Positvie 8 
Score range 3-32 
 
* 1 Chinese Chi ? 33 cm 
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Table 10. Sensitivity (%), specificity (%) and positive predictive value (%) of the risk score, as 
compared with fasting capillary plasma glucose (FCG) and glycated hemoglobin A1c (HbA1c) 
tests at different cut-off points, for predicting undiagnosed diabetes  
 
Number  
(% ) 
Sensitivity 
 (95% CI) 
Specificity 
 (95% CI) 
Positive predict value 
(95% CI) 
Men     
Risk score ? 14 1266(75%) 87.0(82.2-91.7) 27.4(25.0-29.7) 14.4(12.4-16.3) 
Risk score  ? 17 * 773(46%) 64.1(57.3-70.8) 56.7(54.1-59.3) 17.2(15.5-18.9) 
FCG ? 6.25  mmol/l * 645(35%) 71.0(64.3-77.7) 69.7(67.2-72.2) 24.7(22.4-27.1) 
FCG ? 6.10  mmol/l 648(42%) 74.0(67.8-80.2) 62.9(60.3-65.4) 21.8(20.0-23.7) 
FCG ? 5.60 mmol/l 963(62%) 86.5(81.6-91.3) 41.5(38.9-44.1) 17.2(16.2-18.2) 
HbA1c  ?  5.90% * 399(26%) 50.0(42.6-57.4) 76.9(74.6-79.2) 23.3(20.1-26.5) 
Women     
Risk score ? 14 * 1462(55%) 80.7(75.7-85.7) 47.5(45.4-49.6) 15.3(13.4-17.2)  
Risk score ? 17 883(33%) 55.0(48.7-61.4) 69.0(67.0-70.9) 16.9(15.1-18.8) 
FCG ? 6.55 mmol/l * 1003(26%) 65.9(59.5-72.3) 76.4(74.5-78.3) 24.3(22.0-26.5) 
FCG ? 6.10  mmol/l 1009(42%) 71.8(66.1-77.6) 61.1(59.1-63.2) 17.5(16.1-18.9) 
FCG ? 5.60 mmol/l 1489(62%) 84.5(79.9-89.1) 40.2(38.2-42.3) 14.0(13.2-14.7) 
HbA1c ? 5.44% * 1089(47%) 72.0(66.0-78.0) 55.3(53.1-57.5) 15.6(14.4-16.8) 
 
* The optimal cut-off points. 
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Figure 6. Receiver operating characteristic (ROC) curve of the risk score (          ), fasting 
capillary blood glucose test (FCG,          ) and glycated hemoglobin A1c (HbA1c,           ) in 
predicting undiagnosed diabetes in men and women. 
The area under the ROC curve was 63.5% (95% CI, 59.1-67.9%) in men, and 68.9% (63.6-
72.4%) in women for the questionnaire, 76.9% (72.9-80.9%) in men and 76.0% (72.2-79.8%) in 
women for the FCG, and 68.0% (63.6-72.4%) in men and 67.5% (63.6-71.4%) in women for the 
HbA1c. 
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Table 11. Risk assessment scores (questionnaires) developed in Caucasians or other Asian populations, and their performance in the 
Chinese population of the Qingdao survey 2006 
 
Risk assessment scores 
 
Risk factors involved 
Optimal cut-off 
point (range) 
Area under the Roc curve  
(95% CI), % 
Sensitivity (95% CI) at the 
optimal cut-off point, % 
Specificity (95% CI) at the 
optimal cut-off point, % 
In Original 
population 
In Chinese 
in Qingdao 
 
P value† 
In original 
population 
In Chinese 
in Qingdao 
In original 
population 
In Chinese in 
Qingdao 
Cambridge risk model 
(Griffin SJ. et al. 2000) 
Age, sex, drug-treated hypertension, 
corticosteroids treatment, family history 
of diabetes, BMI and smoking 
0.199 80.0 
(68-91) 
67.6 
(65.2-69.3) 
 
0.91 
77.3 
(54.6-92.2) 
42.2 
(37.8-46.6) 
72.0 
(68.0-76.0) 
79.5 
(78.3-80.8) 
Danish Risk score 
(Glumer C. et al. 2004) 
Age, sex, BMI, known history of 
hypertension, diabetes in parents, 
physical activity at leisure time  
29(0-60) 80.4 
(76.5-83.8) 
69.0 
(66.6-71.3) 
 
0.10 
79.3 
(71.4-86.3) 
55.1 
(50.6-59.5) 
68.7 
(67.1-70.3) 
72.1 
(70.7-73.6) 
Indian risk score 
(Ramachandran A. et al. 
2005) 
Age, sex, family history of diabetes, 
BMI, waist circumference, physical 
activity 
21(0-42) 73.2 
(70.2-76.1) 
67.5 
(65.1-70.0) 
 
0.91 
76.6 
(70.9-81.7) 
96.1 
(94.3-97.9) 
59.9 
(58.5-61.3) 
18.7 
(17.4-19.9) 
Rotterdam study 
(Baan CA. et al. 1999) 
Age, sex, drug-treated hypertension, 
BMI 
6(0-22) 68.0 
(64-72) 
63.1 
(60.5-65.8) 
0.002 
 
78.0 18.8 
(15.3-22.3) 
55.0 90.4 
(89.5-91.3) 
Finnish Risk Score 
(Lindström J. et al. 2003) 
Age, BMI, waist, drug-treated 
hypertension, physical inactivity, daily 
consuming vegetable, fruit, or berries 
9(0-20) 85.0 66.5 
(63.7-69.3) 
 
0.92 
78.0 
(71.0-84.0) 
39.5 
(34.6-44.4) 
77.0 
(76.0-79.0) 
80.4 
(79.0-81.7) 
DESIR Risk Score 
(Balkau B. et al. 2008) 
Waist circumference, smoking, 
hypertension, family history of diabetes 
Not available 
(0-5) 
73.3 in 
men, 
83.9 in 
women 
55.4 in men, 
67.9 in 
women 
 
< 0.001 in 
men, 
 
0.13 in 
women 
 
 
- - - - 
Thai Risk Score 
(Aekplakorn W. et al. 
2006) 
Age, sex, BMI, waist circumference, 
hypertension, family history of diabetes 
6 (0-17) 74.0 
(71-78) 
66.2 
(63.7-68.6) 
0.15 
 
77.0 86.8 
(83.7-89.8) 
60.0 32.6 
(31.1-34.1) 
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ADA  recommendation  
(ADA. 2000) * 
Delivery of a baby weighing > 9 pounds, 
diabetes in parents or siblings,  BMI, 
age, physical activity 
10(0-27) 71.0 66.1 
(63.6-68.6) 
 
0.18 
80.0 39.3 
(34.9-43.7) 
34.6 80.1 
(78.9-81.4) 
Qingdao diabetes risk 
score 
Age, waist circumference, diabetes in 
parents or siblings 
14(3-32) 64.2 
(60.3-68.0) 
67.3 
(64.9-69.7) 
 
- 
88.7 
(84.2-93.1) 
84.2 
(81.0-87.5) 
27.1 
(25.0-29.2) 
39.8 
(38.2-41.3) 
* ADA. American Diabetes Association 
† Compared with Qingdao diabetes risk score  
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5.5 Risk prediction models and its performance in Mauritian Indians 
(Paper VI) 
Diabetes developed in 511 out of 3094 Mauritian Indians during follow-up. The baseline 
characteristics of participants by sex and diabetes status at the end of follow-up were shown in 
Table 12. From the whole 3094 participants, 1544 were randomly selected to establish the Cox 
regression model; and, the remaining 1550 were used to validate the models.  There were no 
statistically significant differences in the mean age, BMI, waist, blood pressure, blood glucose 
level, lipids, and, in the proportion of sex, physical activity, education levels, and family history 
of diabetes (FH) between the two groups. The incidence of diabetes was 17.2% in the group used 
to establish the models and 15.8% (X2 = 1.13, df = 1, P = 0.29) in those used to validate the 
models. 
 
Development of risk predicting models  
Among the risk factors tested, obesity (BMI and waist circumference), blood pressure, plasma 
glucose, triglyceride, and family history of diabetes came out to be significant predicators of 
diabetes and were, thus, included in the full model (Table 13). A simple model fitted with BMI, 
waist circumference and FH, and the simple model plus the FPG were also constructed. The 
Akaike’s information criterion value of the full model, simple model and simple model plus the 
FPG were 1284, 1363, and 1287, respectively. A risk chart was constructed with the estimated 
risk probabilities derived from a simple model fitted with FH and obesity (Figure 7).  
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Table 12. The baseline characteristic of the participants who were free of diabetes at baseline stratified by diabetes status at the end of 
the follow-up 
 Indian Men Indian Women 
 Non diabetes Diabetes P value Non diabetes Diabetes P value 
No of cases 1182 259 - 1401 252 - 
Age (year) 39(38.1-39.3) 43(41.5-44.1) < 0.001 39(37.8-39.9) 43(41.6-44.2) < 0.001 
BMI (kg/m2) 22.7(22.5-22.9) 24.9(24.5-25.4) < 0.001 23.7(23.5-24.0) 26.5(25.9-27.0) < 0.001 
Waist (cm) 79.0(78.5-79.5) 84.6(82.5-85.6) < 0.001 74.8(74.3-75.4) 80.8(79.5-82.0) < 0.001 
Systolic blood pressure (mmHg) 122(120.7-122.5) 128(125.7-129.5) < 0.001 118(117.2-118.7) 123(121.4-125.1) < 0.001 
Diastolic blood pressure (mmHg) 76(75.4-76.7) 80(79.0-81.8) < 0.001 73(72.0-73.1) 75(73.9-76.5) < 0.001 
Total cholesterol (mmol/l) 5.30(5.22-5.37) 5.49(5.32-5.65) 0.04 5.00(4.94-5.06) 5.05(4.89-5.20) 0.59 
HDL cholesterol (mmol/l) 1.26(1.24-1.28) 1.18(1.14-1.22) 0.001 1.34(1.33-1.36) 1.26(1.22-1.30) < 0.001 
Triglyceride (mmol/l) 1.58(1.51-1.65) 2.20(2.06-2.35) 0.001 1.11(1.07-1.14) 1.37(1.29-1.45) < 0.001 
Fasting glucose (mmol/l) 5.19(5.17-5.22) 5.62(5.56-5.68) < 0.001 5.07(5.04-5.09) 5.48(5.42-5.54) < 0.001 
2-h postchallenged glucose (mmol/l) 5.74(5.65-5.82) 7.08(6.89-7.26) < 0.001 6.38(6.31-6.46) 7.77(7.60-7.93) < 0.001 
Current smoker (%) 52.9 53.3 0.97 0.8 0.8 0.80 
Alcohol consumption (%) 67.4 76.1 0.03 33.3 35.7 0.62 
Leisure time physical activity (%)   0.001   0.04 
Sedentary 25.0 36.7 - 67.1 70.6 - 
Light 57.0 52.1 - 32.3 27.8 - 
Moderate or heavy 15.8 9.7 - 0.6 1.2 - 
Occupational physical activity (%)   0.10   0.91 
Sedentary 17.8 13.5 - 4.1 3.6 - 
Light 29.3 26.6 - 75.7 76.2 - 
Moderate or heavy 22.4 22.0 - 8.6 9.5 - 
Education (years, %)   <0.001   0.001 
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0 8.5 8.1 - 27.5 30.3 - 
1-6 43.0 56.4 - 47.5 55.8 - 
? 7 48.5 35.5 - 25.1 13.9 - 
Income (Mauritian Rupee, %)   0.17   0.01 
< 2500 30.1 31.4 - 45.6 54.4 - 
2600-5000 50.3 51.2 - 40.7 34.9 - 
> 5000 19.5 17.4 - 12.7 9.1 - 
Current occupation (%)   0.88   0.02 
Professions * 19.9 16.6 - 5.9 2.8 - 
Workers 71.1 73.7 - 29.4 25.8 - 
Not work outside † 9.1 9.7 - 64.7 71.4 - 
Positive Family history of diabetes 
(%) 24.9 21.6 
0.27 22.3 32.5 < 0.001 
Drug treated hypertension (yes, %) 2.7 5.0 0.15 3.9 8.3 0.002 
Data were mean (95%CI) or %. 
* Professions: business managers, technicians, clericals, etc. 
† Not work outside: unemployed, retired, or housewife, etc. 
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Table 13. Regression coefficients and hazard ratio for predicting the development of diabetes in Mauritian Indians 
 Full model 
* Simple model  Simple model with FPG 
 ? coefficient (SE) Hazard ratio (95% CI) ? coefficient (SE) Hazard ratio (95% CI) ? coefficient (SE) Hazard ratio (95% CI) 
Age (years)       
20-29 0.0028(0.0010) - 0.0031(0.0011) - 0.0032(0.0011) - 
30-44 0.0038(0.0004) - 0.0044(0.0005) - 0.0042(0.0042) - 
45-54 0.0054(0.0006) - 0.0079(0.0008) - 0.0062(0.0007) - 
55-65 0.0042(0.0007) - 0.0068(0.0010) - 0.0051(0.0008) - 
Sex, men  -0.0213(0.1660) 0.98(0.71-1.35) 0.4331(0.1199) 1.48(1.14-1.93) 0.2637(0.1247) 1.30(1.02-1.66) 
Body mass index (Kg/m2)       
< 23 - 1.00 - 1.00 - 1.00 
23-24.99 0.3720(0.2424) 1.45(0.90-2.33) 0.5059(0.2349) 1.63(1.02-2.59) 0.4377(0.2414) 1.55(0.96-2.49) 
? 25 0.6412(0.2487) 1.90(1.17-3.09) 0.7943(0.2419) 2.12(1.31-3.43) 0.7517(0.2464) 2.12(1.31-3.43) 
Waist circumference (cm)       
<80 in men, or  
< 70 in women 
- 1.00 - 1.00 - 1.00 
80-89 in men, or 
 70-79 in women 
0.7550(0.2411) 2.12(1.33-3.41) 0.8681(0.2211) 2.57(1.65-4.01) 0.8463(0.2271) 2.33(1.49-3.63) 
? 90 in men, or 
?? 80 in women 
0.9390(0.2904) 2.56(1.45-4.51) 1.0870(0.2684) 3.33(1.95-5.70) 1.0276(0.2742) 2.79(1.63-4.78) 
Family history of diabetes 
 (yes vs no)  
0.3249(0.1410) 1.38(1.05-1.82) 0.3284(0.1351) 1.40(1.07-1.83) 0.2652(0.1370) 1.30(1.00-1.70) 
Fasting glucose (mmol/l)       
< 5.60 - 1.00 Not included Not included - 1.00 
5.60-6.09 0.7233(0.1580) 2.06(1.51-2.81) Not included Not included 0.7592(0.1553) 2.14(1.58-2.89) 
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? 6.10 1.5529(0.1760) 4.72(3.34-6.67) Not included Not included 1.6431(0.1706) 5.17(3.70-7.22) 
Triglyceride ? 1.7 mmol/l 0.3607(0.1461) 1.43(1.08-1.91) Not included Not included Not included Not available 
Systolic blood pressure,  
?? 130 mmHg  
0.2703(0.1410) 1.31(1.00-1.73) Not included Not included Not included Not available 
 
Including all variables with a P value of < 0.05 in the full model.
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Validation of the risk predicting model 
When applying the simple model to the rest of the population in reserved for validation purpose, 
the AUC for the estimated risk probabilities to predict the onset of diabetes was 0.62 (95% CI, 
0.56-0.68) in men and 0.64 (0.59-0.69) in women (Figure 8). Using a cut-off point of 0.12, the 
sensitivity and specificity of the risk probabilities was 0.72 (0.71-0.74) and 0.47 (0.45-0.49) in 
men and 0.77 (0.75-0.78) and 0.50 (0.48-0.52) in women, respectively. With increasing the 
estimated risk probability from ? 0.07, 0.08-0.13, 0.13-0.25 to ? 0.26, the incident of diabetes 
rose from 13.5% (8.2-18.9%), 10.7% (6.5%-15.0%), 17.5% (11.5-23.5%), to 28.3% (22.0%-
34.6%) in men and from 6.0% (3.0-9.1%), 10.4% (6.0-14.8%), 20.0% (14.9-25.1%), to 21.1% 
(15.3-26.8%) in women, respectively. In addition, among those with a risk probability of ? 0.12, 
25.6% of the men and 30.6% of the women who had normal FPG and normal 2hPG at baseline 
survey developed IFG/IGT by the end of follow-up; while in individuals with a score of < 0.12, 
the incidence of IFG/IGT was 18.9% in men [X2 = 3.43, df = 1, P = 0.06] and 15.5% in women 
[X2 = 19.4, df = 1, P < 0.05]). 
 
Adding FPG to the simple model improved the prediction of the model. The area under the ROC 
curve increased from 0.62 (0.56-0.68) to 0.70 (0.64-0.75) in men and from 0.64(0.59-0.69) to 
0.71 (0.66-0.76) in women (c-statistic, p < 0.001) (Figure 8). Further addition of systolic blood 
pressure and triglyceride to the model, i.e. the full model, improved the risk prediction slightly 
over the model with FPG in men (with AUC of 0.71 [0.66-0.77], P = 0.003), but not in women 
(0.71 [0.66-0.76], P = 0.21). 
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Figure 7. Absolute risk probabilities of developing diabetes estimated with regression 
coefficients, derived from the simple model fitted with body mass index, waist circumference 
and family history of diabetes 
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Figure 8. Receiver operating characteristic (ROC) curve for men and women showing predicted 
probabilities of developing diabetes derived from 1) Simple model (          ): fitted with BMI, 
waist girth, and family history of diabetes, adjusting for cohorts; 2) Simple model + FPG (        ); 
3) Full model (        ): Simple model + FPG + systolic blood press and triglyceride. 
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6 DISCUSSIONS 
6.1 Diabetes increases in China 
The results of current studies showed that the prevalence of diabetes in Qingdao City had a 
remarkable increment in only five years, and reached up to 16% in the adults aged 35-74 years. 
This is in line with the findings from other studies (Table 2, 4 and Figure 2) and indicates an 
urgent need to prevent the further increase. 
 
The Qingdao city has undergone a fast social-economic development in the past several years 
(http://www.stats-qd.gov.cn, accessed July 7, 2008). Due to the mechanized farming less labour 
works and less farmers are required; an increasing number of farmers have worked in factories in 
cities. The number of families having cars increased fast in the last 5 years, the sidewalks inside 
the communities are full of parked cars. This has reduced spaces for outdoor activities in the 
urban areas, and reduced the number of people who were used to walk alone the sidewalks after 
the dinner. In addition, entertainments inside the room such as TV, internet, computer games, 
mahjong, etc. have become popular, people enjoyed to spend spare time on these indoor games 
in both rural and urban areas. As a consequence of the changes in lifestyle, obesity was prevalent 
in both urban and rural areas, this plus physical inactivity have to certain extent contributed to 
the increased prevalence of diabetes. It is noticeable that rural citizens caught up their urban 
counterparts with both obesity and diabetes. It can be speculated that diabetes will continue to 
increase in Qingdao with long-term exposure to obesity and physical inactivity if there is no 
lifestyle interventions.   
The knowledge about the diabetes, such as risk factors, treatment, and prevention, etc. was not 
well-known by the residents of Qingdao city. This can be partly reflected by the high proportion 
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of newly diagnosed diabetes in both surveys and decreased proportion of individuals doing 
moderate physical activity. In a response to a multi-choice question on diabetes awareness, half 
of the participants in the 2006 survey did not know whether obesity or physical inactivity 
contribute to the development of diabetes; a large proportion of individuals didn’t do any leisure 
time physical exercise. This is alarming and calls for an immediate action to promote healthy 
lifestyle, in parallel with the economic development.    
6.2 HbA1c and FCG as screening test for undiagnosed diabetes 
FCG might be a good screening test for undiagnosed diabetes, which had an AUC above 76% 
and a sensitivity and specificity above 70% at the optimal cut-off point (Bortheiry et al. 1994; 
Husseini et al. 2000). The FCG test is also available in the most of hospitals and community 
clinics and not very expensive. With the portable glucose measurement system, FCG test even 
can be performed at home. Therefore, FCG might be an appropriate screening test in a screening 
program performed in the hospital or by the healthcare professionals in their routine clinical 
practice. It is noticeable that the two-step screening strategy with FCG as first line screening test 
misses cases with undiagnosed diabetes and pre-diabetes. Even if the cut-off point for a positive 
screening test was set at FCG ? 5.5 mmol/l, there were still 10% or more patients with diabetes 
and 26% individuals with pre-diabetes unidentified. This should be taken into account when an 
optimal cut-off point for a positive screening test was selected. 
 
In previous studies, the sensitivity for detecting diabetes varied from 63.2% to 86.0% and the 
specificity ranged from 82.8% to 97.4% at a given optimal HbA1c cut-off point (Rohlfing et al. 
2000; Colagiuri et al. 2004; Buell et al. 2007), which is higher than the results in the current 
study. In a study among Hong Kong Chinese who were referred to a hospital for confirmative 
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testing for glucose intolerance, an optimal HbA1c cut-off point of 6.1% for detecting 2-hPG ? 
11.1mmol/l was reported, which gave a sensitivity of 77.5% and a specificity of 78.8% (Ko et al. 
1998). This study was, however, carried out among a pre-selected high-risk population for which 
close to one fourth of its participants were diagnosed as having diabetes. Moreover, the 
diagnostic criteria for diabetes in the Hong Kong study were also different from those used in our 
study. The inconsistency in performance of the HbA1c test between studies may have been due to 
the discrepancies in ethnicity, assay methods for HbA1c, the gold standard for diagnosis of 
diabetes, study design (population-based vs. clinical based) and the prevalence of other risk 
factors such as obesity. To what extent these factors affect the performance of the HbA1c need to 
be further investigated. However, our results are consistent with other studies that showed HbA1c 
test did not detect pre-diabetes (Saydah et al. 2002; Mannucci et al. 2003; Colagiuri et al. 2004). 
 
As compared with glucose test, HbA1c has, however, several advantages. It is an indicator of 
long-term glycemia. The HbA1c test does not ask examinees to fast and can be tested at any time 
of a day, has a better reproducibility and is easier to perform than the OGTTs does (Rohlfing et 
al. 2002; Sacks et al. 2002). The result of the current study, however, did not appreciate the use 
of the HbA1c as a screening test when compared with FCG. This is consistent with another study 
conducted in Caucasians (Herdzik et al. 2002). In that study, FCG was more effective than 
HbA1c in discriminating the individuals with abnormal glucose tolerance from those with normal. 
Considering it is the most expensive test, HbA1c as a screening test may not be suitable in low 
income regions with relatively limited resource for medical care unless the cost decreased to an 
affordable level in the future.  
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6.3 The risk assessment algorithms for diabetes 
India and China are the top two countries with the largest number of patients with diabetes in the 
world. And, the proportion of undiagnosed diabetes has been reported to be high about 50% to 
80% (Gu et al. 2003; Sadikot et al. 2004; Dong et al. 2005; Menon et al. 2006; Jia et al. 2007; 
Gao et al. 2008). Considering the large number of individuals with diabetes, high medical cost 
induced by diabetes care, the low diabetes awareness and the low economic status in China and 
India, it is politically and practically important to find a simple risk assessment tool to identify 
undiagnosed diabetes and pre-diabetes in order to provide them with early treatment or lifestyle 
intervention to reduce the burden of the disease.  
 
In the current study, the simple risk score or risk predicting model established on the 
anthropometric measurements and family history of diabetes yielded moderate discrimination in 
Chinese and Mauritian Indians. They are simpler than those existing risk scores and the 
information required are all self-measurable by a layperson. Obesity is a strong modifiable 
lifestyle related risk factor for diabetes, and inclusion of BMI and/or waist circumference in the 
risk score can educate people to reduce weight or keep from weight increase. The omitting of the 
SBP and biochemical measures from the final risk predicting model did not lose much of the 
prediction but simplify the application of the risk assessment tools in lay populations. Thus, the 
current risk scores can be widely distributed to the laypersons, and be helpful in raising the 
public awareness and facilitating the health promotion. Compared with fasting glucose test, the 
performance of the simple risk score or risk predicting model were slightly inferior. But, the 
portable glucose meters are less affordable and currently not available to the most of the 
community dwellers. Most of the glucose tests are performed in hospitals prescribed by a doctor. 
In addition, difficulties to confirm a fasting status and to perform invasive blood sampling limit 
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the usage of fasting glucose test as a mass screening tool. It is widely believed in Chinese that 
drawing a blood sample will damage the essential of the body. Unless necessary, people do not 
want to have a glucose testing. 
 
Many risk assessment tools had been established on age, BMI, waist circumference, and family 
history of diabetes (Table 4). Most of those tools were derived from the data of Caucasian 
populations. The performance of these scores in predicting diabetes is usually moderate, with an 
AUC about 0.70 - 0.85. This is similar with the results presented in this study. However, it 
should be cautious to generalize a tool from its original population to others. When the risk 
assessment tools were applied in a new population, particularly in different races, the 
performance became poorer than in the original population (Table 11) (Rathmann et al. 2005). 
This might be due to the facts that both genetic and the environmental determinants differ 
between different ethnic groups, for example the body size, diet, lifestyle, climate, and response 
to the same outside changes are all different. Thus, ethnic-specific risk assessment tools are 
desired. In case that local score is not available, it is recommended to validate and calibrate an 
existing score according to the data of the local population before adopting it. 
 
In India, two risk scores to screen undiagnosed diabetes were published in 2005 (Table 4) 
(Mohan et al. 2005; Ramachandran et al. 2005). Both were derived from cross-sectional data 
based on age, family history of diabetes and physical activity. The merit of current risk 
assessment model in Mauritian Indian is that it was developed based on prospective data rather 
than cross-sectional data and that absolute risk rather than relative risk was estimated.  
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6.4 The methodology considerations 
6.4.1 The assessment of secular trends of diabetes in Qingdao city 
The secular trend of the prevalence of diabetes in Qingdao city was estimated based on two 
consecutively conducted population-based cross-sectional studies. The two surveys followed the 
same procedures for sampling and for anthropometric and biochemical measurements. This is 
crucial to determine the secular trend of diabetes in a big developing countries like China where 
the economic development, culture, climate, working condition and dietary habits are different in 
different regions and the prevalence of diabetes varies largely across the country (Wang et al. 
1998; Gu et al. 2003). Otherwise, it is hard to differentiate the regional differences and 
methodological variances from the true secular changes in prevalence of diabetes. 
 
The surveys included in the current study had both large sample size and high participation rate 
of above 80%. We checked the data of the non-participants in the OGTTs and found they were 
similar to the participants in age, BMI, waist, family history of diabetes, and physical activity. 
Therefore, the non-responders are less likely to bias the estimation of the prevalence of diabetes. 
 
There is a weakness that the FCG was measured with different devices in the two surveys in 
2001-2002 and 2006. Since there was no cross validation between the Lifescan one Touch II 
glucose testing system and the Bayer Brio Meter Kit at the moment, it cannot be precisely 
estimated what variance will lead to by the two different devices. Despite the different method, 
an increased prevalence of diabetes was observed in the population who were administrated to 
OGTTs directly. Another weakness is that the rural counties included in the two surveys are not 
completely same because the random selection procedure. We compared the prevalence of 
diabetes in Jiaonan where both surveys were made; the prevalence was 9.8% in the early survey 
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and 16.9% in the late survey (X2 = 21.9, P < 0.001). We also checked the prevalence between the 
three rural areas of the 2006 survey and found they did not differ from each other (p>0.05). 
Therefore, it is less likely the increased prevalence in rural was due to the difference in the areas 
selected. 
6.4.2 The development of diabetes risk assessment algorithms 
Obesity (as measured by BMI, waist circumference or waist to hip ratio, etc.), age, family history 
of diabetes, physical inactivity, plasma glucose concentration, blood pressure levels etc. was 
confirmed to be the independent determinant of the risk for diabetes both in Indians and Chinese 
in the current study. Therefore, they were including in developing the risk assessment algorithms. 
In the Chinese risk score, BMI was excluded from the final model because it correlated strongly 
with waist circumference and became non-significant when waist circumference was entered. In 
the Indian risk predicting models, however, both BMI and waist circumference were included in 
the same model. This is because that either BMI or waist circumference contributed to the 
prediction of the model independently. For this reason, BMI and waist circumference were both 
included in the final model to emphasize the importance to the weight control.  
 
Neither the leisure time physical activity nor the occupational physical activities was included in 
the current risk assessment algorithms because they were not included in the final Cox or 
Logistic regression model. This is not surprising because the moderate and heavy leisure time 
physical exercise was not common in Chinese in Qingdao city (18% in men and 16% in women) 
and Indians in Mauritian (22% in men and 9% in women) during the survey period. The variable 
on physical activity, therefore, did not contain informative data to distinguish individuals who 
did intensive exercise from those who did not. And, the exercise intensity may not the same as 
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reported in other studies given the same category of physical activities. For example, most 
Chinese living in urban areas are used to have a relaxing walk around the living areas after 
dinner, and these individuals were all included in the “light” physical activity group. The 
occupational physical activities are closely related with the type of jobs and the economic status 
of the country and might vary between time periods and between living areas; thus, the 
association of the occupational activities and the diabetes incidence is not easy to assess. 
Moreover, the physical activity questionnaires used in both Qingdao and Mauritius studies are 
not evaluated and their reliability is not known. As indicated by Rennie and co-workers that 
physical activity data based on questionnaire is usually not reliable (Rennie et al. 1998).  
6.5 The future prospective 
A community-based Qingdao Diabetes Prevention Program (Qd-DPP) is ongoing in close 
cooperation between the local health care organizations and the University of Helsinki since 
2005. As it was planed, the participants of 2006 survey will be re-examined from August 2009 to 
October 2010, and in 2012-2013. A new cohort (N = 6 000) will be recruited in 2009 and re-
examined in 2012-2013. Thus, the secular changes in prevalence of diabetes will be further 
estimated with the new data. The Chinese diabetes risk score might be further validated with the 
new data, particularly the prospective data. 
 
The Chinese diabetes risk score has been adopted and applied in the Qd-DPP project since 2006. 
It is reported to be acceptable, feasible, applicable and useful for health promotion and high-risk 
identification. Over 912 000 citizens have received the risk assessment questionnaire and 270 
911 people with a risk score>=14 have undergone glucose tests and registered to the Qd-DPP for 
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lifestyle counseling. When the Qd-DPP ends in the December 2012, the benefit and cost of the 
screening program, particularly using the risk score as first step of screening can be evaluated.  
The Indian risk predicting models were developed with the data of Mauritian Indians rather than 
the Asian Indians. Further validation is needed to determine the usefulness in the Asian Indians. 
University of Helsinki is now collaborating the Diabetes Epidemiology Collaborative Analysis 
Of Diagnostic Criteria in Asia (DECODA). There are several Indian Centers participated in the 
DECODA study and supplied their data collected from Asian Indians. It is, thus, possible to 
evaluate the performance of the Mauritian Indian risk predicting models in Asian Indians. The 
Indian risk score can also be evaluated based on mortality data collected in 2008 Mauritius to 
examine whether the score is also able to identify individuals at increased risk for premature 
mortality from cardiovascular and non-cardiovascular disease.
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7. CONCLUSIONS 
 
 
I. The prevalence of type 2 diabetes in Chinese was high and increasing in Qingdao city 
from 2001 to 2006. Action is urgently needed to prevent the epidemic of diabetes. 
 
II. Fasting capillary blood glucose test is an adequate screening test for detecting 
undiagnosed diabetes in a mass screening program. But, it should be noticed that the two-
step screening strategy based on FCG as a first line screening test and followed by a 
standard oral glucose tolerance test will miss a number of patients with undiagnosed 
diabetes and pre-diabetes. This should be taken into account when an optimal cut-off 
point for a positive screening test was selected. 
 
III. The performance of a simple risk score comprising modifiable lifestyle factors is 
moderate, and it is a good alternative screening test in screening programs covering large 
population or as a first-step screening tool in a multi-steps screening program. It can also 
serve as a useful health promotion tool in a prevention program. 
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